NF-M	B-protein
(	O
chicken	B-protein
C/EBP	I-protein
beta	I-protein
)	O
induces	O
eosinophilic	O
differentiation	O
and	O
apoptosis	O
in	O
a	O
hematopoietic	B-cell_line
progenitor	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

CAAT/enhancer	B-protein
binding	I-protein
proteins	I-protein
(	O
C/EBPs	B-protein
)	O
are	O
transcriptional	O
activators	O
implicated	O
in	O
the	O
differentiation	O
processes	O
of	O
various	O
cell	O
lineages	O
.	O

We	O
have	O
shown	O
earlier	O
that	O
NF-M	B-protein
,	O
the	O
chicken	B-protein
homolog	I-protein
of	O
C/EBP	B-protein
beta	I-protein
,	O
is	O
specifically	O
expressed	O
in	O
myelomonocytic	B-cell_type
and	I-cell_type
eosinophilic	I-cell_type
cells	I-cell_type
of	O
the	O
hematopoietic	O
system	O
.	O

To	O
investigate	O
the	O
role	O
of	O
NF-M	B-protein
in	O
hematopoietic	B-cell_line
cell	I-cell_line
lineage	I-cell_line
commitment	O
,	O
we	O
constructed	O
a	O
conditional	O
form	O
of	O
the	O
protein	O
by	O
fusing	O
it	O
to	O
the	O
hormone	B-protein
binding	I-protein
domain	I-protein
of	O
the	O
human	B-protein
estrogen	I-protein
receptor	I-protein
.	O

This	O
construct	O
was	O
stably	O
expressed	O
in	O
a	O
multipotent	B-cell_line
progenitor	I-cell_line
cell	I-cell_line
line	I-cell_line
transformed	O
by	O
the	O
Myb-Ets	B-protein
oncoprotein	I-protein
.	O

We	O
report	O
here	O
that	O
both	O
NF-M-dependent	B-DNA
promoter	I-DNA
constructs	I-DNA
and	O
resident	O
genes	O
could	O
be	O
activated	O
by	O
addition	O
of	O
beta-estradiol	O
to	O
the	O
NF-M-estrogen	B-cell_line
receptor	I-cell_line
expressing	I-cell_line
progenitors	I-cell_line
.	O

At	O
the	O
same	O
time	O
,	O
we	O
observed	O
a	O
down-regulation	O
of	O
progenitor-specific	B-protein
surface	I-protein
markers	I-protein
and	O
the	O
up-regulation	O
of	O
differentiation	B-protein
markers	I-protein
restricted	O
to	O
the	O
eosinophil	B-cell_type
and	O
myeloid	B-cell_type
lineages	I-cell_type
.	O

In	O
addition	O
to	O
the	O
onset	O
of	O
differentiation	O
,	O
cell	O
death	O
was	O
induced	O
with	O
typical	O
apoptotic	O
features	O
.	O

Our	O
results	O
suggest	O
that	O
NF-M	B-protein
plays	O
an	O
important	O
role	O
in	O
commitment	O
along	O
the	O
eosinophil	B-cell_type
lineage	I-cell_type
and	O
in	O
the	O
induction	O
of	O
apoptosis	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.14	NULL
no.24	NULL
pp.6127-6135	NULL
,	NULL
1995	NULL
NF-M	NULL
(	NULL
chicken	NULL
C/EBPB	NULL
)	NULL
induces	NULL
eosinophilic	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
in	NULL
a	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
line	NULL
Christine	NULL
Muller	NULL
,	NULL
Elisabeth	NULL
Kowenz-Leutz	NULL
,	NULL
Sigrid	NULL
Grieser-Ade	NULL
'	NULL
,	NULL
Thomas	NULL
Graf	NULL
and	NULL
Achim	NULL
Leutz2	NULL
Max-Delbriick-Centrum	NULL
fiir	NULL
Molekulare	NULL
Medizin	NULL
,	NULL
Robert	NULL
Réssle	NULL
Strasse	NULL
10	NULL
,	NULL
13122	NULL
Berlin	NULL
and	NULL
'Differentiation	NULL
Programme	NULL
,	NULL
European	NULL
Molecular	NULL
Biology	NULL
Laboratorium	NULL
,	NULL
Meyerhofstrasse	NULL
1	NULL
,	NULL
Postfach	NULL
102209	NULL
,	NULL
69012	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
*Corresponding	NULL
author	NULL
CAAT/enhancer	NULL
binding	NULL
proteins	NULL
(	NULL
C/EBPs	NULL
)	NULL
are	NULL
transcriptional	NULL
activators	NULL
implicated	NULL
in	NULL
the	NULL
differentiation	NULL
processes	NULL
of	NULL
various	NULL
cell	NULL
lineages	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
earlier	NULL
that	NULL
NF-M	NULL
,	NULL
the	NULL
chicken	NULL
homolog	NULL
of	NULL
C/EBPR	NULL
,	NULL
is	NULL
specifically	NULL
expressed	NULL
in	NULL
myelomonocytic	NULL
and	NULL
eosinophilic	NULL
cells	NULL
of	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
NF-M	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lineage	NULL
commit-ment	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
conditional	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
by	NULL
fusing	NULL
it	NULL
to	NULL
the	NULL
hormone	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
stably	NULL
expressed	NULL
in	NULL
a	NULL
multipotent	NULL
progenitor	NULL
cell	NULL
line	NULL
transformed	NULL
by	NULL
the	NULL
Myb-Ets	NULL
oncoprotein	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
both	NULL
NF-M-dependent	NULL
promoter	NULL
constructs	NULL
and	NULL
resident	NULL
genes	NULL
could	NULL
be	NULL
activated	NULL
by	NULL
addition	NULL
of	NULL
B-estradiol	NULL
to	NULL
the	NULL
NF-M-estrogen	NULL
receptor	NULL
expressing	NULL
progenitors	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
down-regulation	NULL
of	NULL
progenitor-specific	NULL
surface	NULL
markers	NULL
and	NULL
the	NULL
up-regulation	NULL
of	NULL
differentiation	NULL
markers	NULL
restricted	NULL
to	NULL
the	NULL
eosinophil	NULL
and	NULL
myeloid	NULL
lineages	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
onset	NULL
of	NULL
differentiation	NULL
,	NULL
cell	NULL
death	NULL
was	NULL
induced	NULL
with	NULL
typical	NULL
apoptotic	NULL
features	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
NF-M	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
commitment	NULL
along	NULL
the	NULL
eosinophil	NULL
lineage	NULL
and	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Keywords	NULL
:	NULL
cell	NULL
transformation/nuclear	NULL
oncogenes/stem	NULL
cells/transcription	NULL
factors	NULL
Introduction	NULL
Transcription	NULL
factors	NULL
of	NULL
the	NULL
C/EBPB	NULL
(	NULL
CAAT/enhancer	NULL
binding	NULL
protein	NULL
)	NULL
family	NULL
are	NULL
involved	NULL
in	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
of	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
Umek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Freytag	NULL
and	NULL
Geddes	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Common	NULL
structural	NULL
features	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
highly	NULL
conserved	NULL
basic	NULL
DNA	NULL
binding	NULL
and	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
domains	NULL
at	NULL
the	NULL
carboxyl-terminus	NULL
and	NULL
divergent	NULL
amino-termini	NULL
containing	NULL
regulatory	NULL
and	NULL
transactivation	NULL
domains	NULL
(	NULL
Landschulz	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1988	NULL
,	NULL
1989	NULL
;	NULL
Pei	NULL
and	NULL
Shih	NULL
,	NULL
1991	NULL
;	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
first	NULL
member	NULL
of	NULL
this	NULL
family	NULL
,	NULL
C/EBPa	NULL
,	NULL
was	NULL
originally	NULL
identified	NULL
in	NULL
liver	NULL
tissue	NULL
but	NULL
is	NULL
now	NULL
known	NULL
also	NULL
to	NULL
be	NULL
expressed	NULL
during	NULL
later	NULL
stages	NULL
of	NULL
adipocyte	NULL
differentiation	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
C/EBPa	NULL
in	NULL
adipo-blasts	NULL
inhibits	NULL
cell	NULL
proliferation	NULL
(	NULL
Umek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
activates	NULL
genes	NULL
characteristic	NULL
for	NULL
differentiated	NULL
fat	NULL
cells	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
(	NULL
Christy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Herrera	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Kaestner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Freytag	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
C/EBP	NULL
antisense	NULL
RNA	NULL
blocks	NULL
terminal	NULL
differentiation	NULL
of	NULL
adipoblasts	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
essential	NULL
for	NULL
adipocyte	NULL
differentiation	NULL
(	NULL
Lin	NULL
and	NULL
Lane	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Similarly	NULL
to	NULL
what	NULL
has	NULL
been	NULL
found	NULL
in	NULL
adipocyte	NULL
differentiation	NULL
,	NULL
cessation	NULL
of	NULL
cell	NULL
proliferation	NULL
correlates	NULL
with	NULL
C/EBPB	NULL
accumulation	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
ectopic	NULL
expression	NULL
of	NULL
C/EBPB	NULL
arrests	NULL
hepatoma	NULL
cell	NULL
growth	NULL
(	NULL
Buck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Another	NULL
tissue	NULL
in	NULL
which	NULL
C/EBP-type	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
is	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

As	NULL
observed	NULL
for	NULL
adipocyte	NULL
maturation	NULL
,	NULL
myelomonocytic	NULL
differentiation	NULL
is	NULL
paralleled	NULL
by	NULL
a	NULL
distinct	NULL
expression	NULL
pattern	NULL
of	NULL
C/EBP	NULL
proteins	NULL
which	NULL
,	NULL
however	NULL
,	NULL
is	NULL
different	NULL
from	NULL
that	NULL
in	NULL
adipocytes	NULL
(	NULL
Cao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Natsuka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
C/EBPB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
and	NULL
active	NULL
in	NULL
macrophages	NULL
during	NULL
the	NULL
inflammatory	NULL
reaction	NULL
and	NULL
acute	NULL
phase	NULL
response	NULL
(	NULL
Akira	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Poli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Akira	NULL
and	NULL
Kishimoto	NULL
,	NULL
1992	NULL
;	NULL
Juan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ramji	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Pope	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
NF-M	NULL
,	NULL
the	NULL
chicken	NULL
homolog	NULL
of	NULL
C/EBP	NULL
$	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
of	NULL
the	NULL
chicken	NULL
hematopoietic	NULL
system	NULL
(	NULL
Sterneck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
,	NULL
b	NULL
;	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
we	NULL
also	NULL
found	NULL
it	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
Myb-Ets-transformed	NULL
eosinophils	NULL
(	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
NF-M	NULL
during	NULL
lineage	NULL
commitment	NULL
was	NULL
suggested	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
NF-M	NULL
expression	NULL
was	NULL
detected	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
during	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
Myb-Ets-transformed	NULL
multipotent	NULL
precursor	NULL
cells	NULL
(	NULL
MEPs	NULL
)	NULL
into	NULL
eosinophils	NULL
and	NULL
myeloblasts	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-M	NULL
was	NULL
found	NULL
to	NULL
collaborate	NULL
with	NULL
both	NULL
cellular	NULL
and	NULL
several	NULL
viral	NULL
forms	NULL
of	NULL
the	NULL
Myb	NULL
oncoprotein	NULL
to	NULL
activate	NULL
the	NULL
resident	NULL
Myb	NULL
target	NULL
gene	NULL
mim-1	NULL
even	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
fibroblasts	NULL
(	NULL
Burk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ness	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
combinatorial	NULL
action	NULL
of	NULL
Myb	NULL
and	NULL
C/EBP	NULL
proteins	NULL
constitutes	NULL
a	NULL
bipartite	NULL
switch	NULL
which	NULL
serves	NULL
as	NULL
a	NULL
signal	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
myeloid-specific	NULL
genes	NULL
(	NULL
Ness	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
activating	NULL
signal	NULL
transduc-tion	NULL
pathways	NULL
(	NULL
Wegner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Nakajima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Trautwein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
suggests	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
factor	NULL
is	NULL
tightly	NULL
linked	NULL
to	NULL
various	NULL
onco-developmental	NULL
cues	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
that	NULL
activation	NULL
of	NULL
NF-M-estrogen	NULL
receptor	NULL
(	NULL
ER	NULL
)	NULL
by	NULL
estrogen	NULL
in	NULL
the	NULL
MEP	NULL
cell	NULL
line	NULL
HD57	NULL
caused	NULL
a	NULL
suppression	NULL
of	NULL
MEP	NULL
-specific	NULL
antigens	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
eosinophilic/myelomonocytic	NULL
differentiation	NULL
markers	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
observed	NULL
massive	NULL
cell	NULL
death	NULL
with	NULL
typical	NULL
features	NULL
of	NULL
apoptosis	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
NF-M	NULL
(	NULL
C/EBP	NULL
$	NULL
3	NULL
)	NULL
in	NULL
hematopoietic	NULL
differentiation	NULL
as	NULL
well	NULL
as	NULL
in	NULL
programed	NULL
cell	NULL
death	NULL
.	NULL

6127	NULL
C.Miller	NULL
et	NULL
al	NULL
.	NULL

A	NULL
B	NULL
z	NULL
2.04	NULL
2	NULL
X	NULL
E	NULL
5	NULL
1.51	NULL
r=	NULL
9	NULL
€	NULL
10	NULL
!	NULL

s	NULL
bd	NULL
5	NULL
5	NULL
g	NULL
-	NULL
0.5	NULL
®	NULL
B-estradiol|	NULL
~	NULL
|	NULL
+	NULL
|	NULL
~	NULL
|	NULL
+	NULL
|	NULL
~	NULL
|	NULL
+	NULL
|	NULL
~	NULL
|	NULL
+	NULL
vector	NULL
vector	NULL
aim	NULL
,	NULL
control	NULL
NF-MWER	NULL
|	NULL
-	NULL
|NF-WER	NULL
reporter	NULL
pM	NULL
82	NULL
cMGF-Luc	NULL
PBG-Lue	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
erythroblast	NULL
cell	NULL
line	NULL
HD3	NULL
was	NULL
transiently	NULL
cotransfected	NULL
with	NULL
the	NULL
NF-M-ER	NULL
expression	NULL
vector	NULL
and	NULL
two	NULL
different	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
containing	NULL
either	NULL
a	NULL
palindromic	NULL
NF-M	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
cMGF	NULL
promotor	NULL
(	NULL
pM82cMGF	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
erythroid-specific	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
promotor	NULL
(	NULL
PBG	NULL
Luc	NULL
)	NULL
(	NULL
B	NULL
)	NULL
which	NULL
is	NULL
not	NULL
NF-M	NULL
responsive	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
or	NULL
mock	NULL
treated	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
plotted	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
duplicates	NULL
.	NULL

Results	NULL
Construction	NULL
of	NULL
a	NULL
hormone-inducible	NULL
form	NULL
of	NULL
NF-M	NULL
To	NULL
investigate	NULL
the	NULL
function	NULL
of	NULL
NF-M	NULL
in	NULL
hematopoietic	NULL
differentiation	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
conditional	NULL
form	NULL
of	NULL
the	NULL
transactivator	NULL
protein	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
fused	NULL
the	NULL
C-terminus	NULL
of	NULL
NF-M	NULL
to	NULL
the	NULL
hormone	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
(	NULL
Greene	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
construct	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
chicken	NULL
B-actin	NULL
promoter	NULL
and	NULL
carries	NULL
the	NULL
histidinol	NULL
resistance	NULL
gene	NULL
as	NULL
a	NULL
selectable	NULL
marker	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
NF-M-ER	NULL
were	NULL
tested	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
cMGF	NULL
promoter	NULL
(	NULL
pM82	NULL
)	NULL
which	NULL
contains	NULL
a	NULL
palindromic	NULL
NF-M	NULL
binding	NULL
site	NULL
(	NULL
Sterneck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
;	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
NF-M-ER	NULL
and	NULL
the	NULL
reporter	NULL
construct	NULL
into	NULL
the	NULL
erythroblast	NULL
cell	NULL
line	NULL
HD3	NULL
(	NULL
Beug	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
showed	NULL
an	NULL
~20-fold	NULL
increase	NULL
of	NULL
reporter	NULL
expression	NULL
after	NULL
addition	NULL
of	NULL
B-estradiol	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
same	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hormone	NULL
or	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
reporter	NULL
containing	NULL
an	NULL
NF-M-unresponsive	NULL
promoter	NULL
(	NULL
PBG	NULL
luc	NULL
containing	NULL
the	NULL
erythroid	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
promoter	NULL
)	NULL
(	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
was	NULL
not	NULL
activated	NULL
by	NULL
the	NULL
NF-M-ER	NULL
construct	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
showed	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
is	NULL
hormone	NULL
inducible	NULL
and	NULL
specific	NULL
for	NULL
NF-M	NULL
target	NULL
sites	NULL
.	NULL

NF-M	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
mim-1	NULL
in	NULL
a	NULL
transformed	NULL
multipotent	NULL
cell	NULL
line	NULL
To	NULL
determine	NULL
whether	NULL
NF-M	NULL
expression	NULL
can	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
multipotent	NULL
hematopoietic	NULL
cells	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
NF-M-ER	NULL
vector	NULL
into	NULL
the	NULL
MEP	NULL
cell	NULL
line	NULL
HD357	NULL
and	NULL
seeded	NULL
the	NULL
cells	NULL
in	NULL
semi-solid	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
histidinol	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
had	NULL
been	NULL
derived	NULL
from	NULL
chicken	NULL
blastoderm	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
Gag-Myb-Ets	NULL
fusion	NULL
protein	NULL
of	NULL
the	NULL
E26	NULL
virus	NULL
,	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
6128	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

NF-M-ER	NULL
fusion	NULL
protein	NULL
expression	NULL
in	NULL
HD57	NULL
MEP	NULL
cells	NULL
.	NULL

HD57	NULL
MEP	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
NF-M-ER	NULL
construct	NULL
and	NULL
selected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
histidinol	NULL
in	NULL
semi-solid	NULL
medium	NULL
.	NULL

Fifteen	NULL
resistant	NULL
colonies	NULL
(	NULL
#	NULL
1-15	NULL
)	NULL
were	NULL
isolated	NULL
and	NULL
expanded	NULL
in	NULL
liquid	NULL
medium	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
blotted	NULL
and	NULL
subjected	NULL
to	NULL
immunodetection	NULL
using	NULL
a	NULL
polyclonal	NULL
NF-M	NULL
antiserum	NULL
.	NULL

Lysates	NULL
from	NULL
HD11	NULL
macrophages	NULL
which	NULL
express	NULL
NF-M	NULL
(	NULL
C1	NULL
)	NULL
and	NULL
from	NULL
HD57	NULL
MEP	NULL
cells	NULL
which	NULL
are	NULL
devoid	NULL
of	NULL
NF-M	NULL
(	NULL
C2	NULL
)	NULL
were	NULL
included	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

Twelve	NULL
out	NULL
of	NULL
15	NULL
clones	NULL
express	NULL
the	NULL
NF-M-ER	NULL
construct	NULL
(	NULL
electrophoretic	NULL
mobility	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrowhead	NULL
on	NULL
the	NULL
left	NULL
)	NULL
.	NULL

Molecular	NULL
weight	NULL
standards	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

and	NULL
eosinophilic	NULL
lineages	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
obtained	NULL
15	NULL
stably	NULL
transfected	NULL
clones	NULL
,	NULL
12	NULL
of	NULL
which	NULL
expressed	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
these	NULL
clones	NULL
(	NULL
cl.3	NULL
,	NULL
c1.6	NULL
and	NULL
cl.14	NULL
)	NULL
were	NULL
used	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Both	NULL
the	NULL
NF-M-ER-expressing	NULL
clones	NULL
and	NULL
the	NULL
parental	NULL
HD57	NULL
MEP	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
-estradiol	NULL
for	NULL
different	NULL
time	NULL
periods	NULL
and	NULL
examined	NULL
by	NULL
Northern	NULL
analysis	NULL
for	NULL
expression	NULL
of	NULL
mim-1	NULL
as	NULL
a	NULL
myeloid/eosinophil-specific	NULL
NF-M	NULL
target	NULL
gene	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

In	NULL
B-estradiol-treated	NULL
NF-M-ER	NULL
cells	NULL
,	NULL
mim-/-specific	NULL
message	NULL
was	NULL
detectable	NULL
within	NULL
1	NULL
h	NULL
and	NULL
still	NULL
increased	NULL
after	NULL
34	NULL
h	NULL
of	NULL
hormone	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mim-/	NULL
message	NULL
was	NULL
neither	NULL
detected	NULL
in	NULL
the	NULL
untreated	NULL
NF-M-ER-expressing	NULL
HD57	NULL
MEP	NULL
cells	NULL
nor	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
treated	NULL
with	NULL
B-estradiol	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

This	NULL
result	NULL
shows	NULL
that	NULL
NF-M	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
myeloid/eosinophilic	NULL
marker	NULL
in	NULL
a	NULL
multipotent	NULL
precursor	NULL
cell	NULL
line	NULL
.	NULL

Next	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
genes	NULL
is	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
chimeric	NULL
NF-M-ER	NULL
protein	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
possibility	NULL
,	NULL
protein	NULL
synthesis	NULL
of	NULL
c1.6	NULL
NF-M-ER	NULL
cells	NULL
was	NULL
blocked	NULL
with	NULL
cycloheximide	NULL
before	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
B-estradiol	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
was	NULL
then	NULL
determined	NULL
by	NULL
Northern	NULL
blotting	NULL
in	NULL
NF-M-ER	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Figure	NULL
4	NULL
,	NULL
the	NULL
treatment	NULL
with	NULL
cycloheximide	NULL
at	NULL
a	NULL
concentration	NULL
that	NULL
inhibits	NULL
>	NULL
90	NULL
%	NULL
of	NULL
protein	NULL
synthesis	NULL
(	NULL
Kraut	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
induction	NULL
of	NULL
mim-/	NULL
message	NULL
by	NULL
the	NULL
hormone	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
no	NULL
mim-/	NULL
RNA	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
after	NULL
the	NULL
same	NULL
treatment	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
NF-M	NULL
directly	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
myeloid/eosinophil-specific	NULL
gene	NULL
in	NULL
MEP	NULL
cells	NULL
.	NULL

NF-M	NULL
induces	NULL
the	NULL
down-regulation	NULL
of	NULL
MEP/thrombocyte-specific	NULL
markers	NULL
and	NULL
the	NULL
up-regulation	NULL
of	NULL
eosinophilic	NULL
markers	NULL
To	NULL
determine	NULL
whether	NULL
forced	NULL
NF-M	NULL
expression	NULL
alters	NULL
the	NULL
phenotype	NULL
of	NULL
HD57	NULL
MEP	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
antigens	NULL
by	NULL
cytofluorometric	NULL
analysis	NULL
using	NULL
mim-1	NULL
expression	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
4	NULL
B	NULL
12	NULL
16	NULL
20	NULL
24	NULL
28	NULL
32	NULL
36	NULL
hours	NULL
of	NULL
B-estradio	NULL
!	NULL

treatment	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Kinetics	NULL
of	NULL
mim-/	NULL
expression	NULL
after	NULL
activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
chimera	NULL
.	NULL

Parental	NULL
cells	NULL
and	NULL
NF-M-ER-expressing	NULL
cells	NULL
(	NULL
cl.6	NULL
)	NULL
were	NULL
treated	NULL
or	NULL
mock	NULL
treated	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
different	NULL
times	NULL
as	NULL
indicated	NULL
.	NULL

Northern	NULL
analysis	NULL
with	NULL
>	NULL
°P-labeled	NULL
DNA	NULL
probes	NULL
for	NULL
mim-/	NULL
and	NULL
chicken	NULL
GAPDH	NULL
was	NULL
performed	NULL
and	NULL
radioactivity	NULL
was	NULL
evaluated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
normalized	NULL
to	NULL
GAPDH	NULL
expression	NULL
and	NULL
plotted	NULL
.	NULL

Closed	NULL
circles	NULL
:	NULL
NF-M-ER	NULL
c1.6	NULL
plus	NULL
B-estradiol	NULL
;	NULL
triangles	NULL
:	NULL
NF-M-ER	NULL
cl.6	NULL
without	NULL
hormone	NULL
;	NULL
open	NULL
circles	NULL
:	NULL
parental	NULL
cells	NULL
plus	NULL
B-estradiol	NULL
.	NULL

specific	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
MEP21	NULL
and	NULL
MEP26	NULL
,	NULL
two	NULL
surface	NULL
antigens	NULL
which	NULL
are	NULL
characteristic	NULL
for	NULL
MEP	NULL
cells	NULL
and	NULL
normal	NULL
thrombocytes	NULL
,	NULL
was	NULL
strongly	NULL
down-regulated	NULL
within	NULL
3	NULL
days	NULL
after	NULL
B-estradiol	NULL
treatment	NULL
(	NULL
MEP26	NULL
:	NULL
from	NULL
92	NULL
to	NULL
17	NULL
%	NULL
;	NULL
MEP21	NULL
:	NULL
from	NULL
94	NULL
to	NULL
38	NULL
%	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
the	NULL
eosinophil-specific	NULL
surface	NULL
marker	NULL
EOS47	NULL
was	NULL
up-regulated	NULL
in	NULL
40	NULL
%	NULL
of	NULL
the	NULL
population	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
6	NULL
%	NULL
of	NULL
the	NULL
viable	NULL
hormone-treated	NULL
cells	NULL
expressed	NULL
eosinophil-specific	NULL
peroxidase	NULL
while	NULL
no	NULL
peroxidase-positive	NULL
cells	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
controls	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
changes	NULL
in	NULL
surface	NULL
marker	NULL
expression	NULL
were	NULL
observed	NULL
after	NULL
-estradiol	NULL
treatment	NULL
of	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
another	NULL
experiment	NULL
,	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
altered	NULL
expression	NULL
of	NULL
MEP21	NULL
,	NULL
MEP26	NULL
and	NULL
EOS47	NULL
antigens	NULL
was	NULL
determined	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Figure	NULL
5B	NULL
,	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
MEP	NULL
antigens	NULL
was	NULL
already	NULL
observed	NULL
after	NULL
1	NULL
day	NULL
of	NULL
B-estradiol	NULL
treatment	NULL
,	NULL
while	NULL
the	NULL
number	NULL
of	NULL
EOS47	NULL
antigen-positive	NULL
cells	NULL
increased	NULL
only	NULL
after	NULL
2	NULL
days	NULL
.	NULL

Finally	NULL
,	NULL
no	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
myelomonocytic-specific	NULL
cell	NULL
surface	NULL
antigens	NULL
MYLS1/2	NULL
and	NULL
4M12	NULL
could	NULL
be	NULL
detected	NULL
even	NULL
4	NULL
days	NULL
after	NULL
hormone	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NF-M	NULL
expression	NULL
causes	NULL
the	NULL
down-regulation	NULL
of	NULL
MEP/thrombocyte-specific	NULL
cell	NULL
surface	NULL
antigens	NULL
and	NULL
the	NULL
up-regulation	NULL
of	NULL
eosinophil-specific	NULL
markers	NULL
.	NULL

NF-M	NULL
is	NULL
expressed	NULL
in	NULL
normal	NULL
cells	NULL
of	NULL
the	NULL
eosinophilic	NULL
lineage	NULL
The	NULL
results	NULL
presented	NULL
,	NULL
together	NULL
with	NULL
the	NULL
earlier	NULL
observation	NULL
that	NULL
NF-M	NULL
is	NULL
expressed	NULL
in	NULL
Myb-Ets-transformed	NULL
eosinophils	NULL
(	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
NF-M	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
eosinophilic	NULL
in	NULL
addition	NULL
to	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
this	NULL
could	NULL
also	NULL
represent	NULL
an	NULL
artefact	NULL
of	NULL
transformed	NULL
cells	NULL
lines	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
test	NULL
whether	NULL
normal	NULL
eosinophils	NULL
also	NULL
express	NULL
NF-M	NULL
,	NULL
we	NULL
prepared	NULL
chicken	NULL
bone	NULL
marrow	NULL
and	NULL
performed	NULL
in	NULL
situ	NULL
peroxidase	NULL
staining	NULL
to	NULL
reveal	NULL
the	NULL
eosinophils	NULL
(	NULL
Brune	NULL
and	NULL
Spitznagel	NULL
,	NULL
1973	NULL
;	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Following	NULL
the	NULL
peroxidase	NULL
reaction	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
by	NULL
indirect	NULL
immunofluo-	NULL
Differentiation	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
C/EBPRB	NULL
HDS7	NULL
HDS7	NULL
parental	NULL
NF-MW/ER	NULL
-	NULL
T4+	NULL
]	NULL
-	NULL
l+	NULL
)	NULL
+	NULL
CHX	NULL
-	NULL
|	NULL
4+	NULL
|-	NULL
|-	NULL
|	NULL
4+	NULL
]	NULL
|	NULL
estrogen	NULL
WB	NULL
|-NE-M/ER	NULL
WW	NULL
|-	NULL
mim-1	NULL
yﬁﬂmw	NULL
-	NULL
GAPDH	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
myelomonocytic	NULL
genes	NULL
by	NULL
NF-M-ER	NULL
is	NULL
protein	NULL
synthesis	NULL
independent	NULL
.	NULL

NF-M-ER-expressing	NULL
cells	NULL
(	NULL
c1.6	NULL
,	NULL
2X	NULL
10	NULL
``	NULL
cells/	NULL
lane	NULL
)	NULL
and	NULL
parental	NULL
HDS57	NULL
MEP	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
or	NULL
mock	NULL
treated	NULL
as	NULL
indicated	NULL
30	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
2.5	NULL
h	NULL
later	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
a	NULL
Northern	NULL
analysis	NULL
with	NULL
*°P-labeled	NULL
DNA	NULL
probes	NULL
for	NULL
NF-M	NULL
,	NULL
mim-	NULL
]	NULL
and	NULL
GAPDH	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

rescence	NULL
with	NULL
polyclonal	NULL
NF-M	NULL
antiserum	NULL
and	NULL
examined	NULL
microscopically	NULL
.	NULL

All	NULL
of	NULL
the	NULL
peroxidase-positive	NULL
cells	NULL
with	NULL
an	NULL
intact	NULL
nucleus	NULL
were	NULL
also	NULL
NF-M	NULL
positive	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
relatively	NULL
high	NULL
proportion	NULL
of	NULL
cells	NULL
could	NULL
be	NULL
observed	NULL
which	NULL
were	NULL
peroxidase	NULL
negative	NULL
but	NULL
NF-M	NULL
positive	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
latter	NULL
probably	NULL
represent	NULL
myelomonocytic	NULL
cells	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
possibly	NULL
immature	NULL
eosinophils	NULL
.	NULL

This	NULL
is	NULL
illustrated	NULL
in	NULL
Figure	NULL
6	NULL
which	NULL
shows	NULL
two	NULL
NF-M-positive	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
,	NULL
one	NULL
of	NULL
which	NULL
exhibits	NULL
characteristic	NULL
peroxidase-positive	NULL
granules	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
NF-M	NULL
is	NULL
not	NULL
only	NULL
expressed	NULL
in	NULL
normal	NULL
myelomonocytic	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
normal	NULL
eosinophilic	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
in	NULL
HD57	NULL
MEP	NULL
cells	NULL
also	NULL
induces	NULL
apoptosis	NULL
During	NULL
the	NULL
course	NULL
of	NULL
the	NULL
experiments	NULL
described	NULL
above	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
when	NULL
NF-M-ER	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
more	NULL
than	NULL
2	NULL
days	NULL
with	NULL
B-estradiol	NULL
,	NULL
a	NULL
large	NULL
proportion	NULL
of	NULL
the	NULL
cells	NULL
died	NULL
.	NULL

Figure	NULL
7A	NULL
and	NULL
B	NULL
show	NULL
the	NULL
kinetics	NULL
of	NULL
cell	NULL
death	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
for	NULL
two	NULL
NF-M-ER-expressing	NULL
HD57	NULL
MEP	NULL
clones	NULL
following	NULL
hormone	NULL
addition	NULL
.	NULL

After	NULL
4	NULL
days	NULL
of	NULL
B-estradiol	NULL
treatment	NULL
,	NULL
cell	NULL
viability	NULL
was	NULL
reduced	NULL
to	NULL
~10	NULL
and	NULL
30	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
toxicity	NULL
of	NULL
the	NULL
hormone	NULL
since	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
remained	NULL
fully	NULL
viable	NULL
(	NULL
Figure	NULL
7C	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
effect	NULL
was	NULL
due	NULL
to	NULL
the	NULL
cryptic	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
estrogen	NULL
binding	NULL
domain	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
4-hydroxytamoxifen	NULL
(	NULL
40HT	NULL
)	NULL
.	NULL

This	NULL
estrogen	NULL
antagonist	NULL
still	NULL
dissociates	NULL
the	NULL
hormone	NULL
receptor	NULL
from	NULL
the	NULL
heat	NULL
shock	NULL
protein	NULL
Hsp90	NULL
(	NULL
Catelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Rebbe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Picard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
whilst	NULL
selectively	NULL
blocking	NULL
its	NULL
cryptic	NULL
transactivation	NULL
potential	NULL
(	NULL
Berry	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Pham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7A	NULL
and	NULL
B	NULL
,	NULL
40HT	NULL
treatment	NULL
exibited	NULL
the	NULL
same	NULL
ability	NULL
as	NULL
B-estradiol	NULL
to	NULL
cause	NULL
cell	NULL
death	NULL
.	NULL

When	NULL
the	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
semi-solid	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
B-estradiol	NULL
and	NULL
histidinol	NULL
,	NULL
a	NULL
small	NULL
number	NULL
of	NULL
colonies	NULL
was	NULL
obtained	NULL
.	NULL

However	NULL
,	NULL
of	NULL
14	NULL
such	NULL
clones	NULL
examined	NULL
,	NULL
none	NULL
6129	NULL
C.Miller	NULL
ot	NULL
al	NULL
.	NULL

A	NULL
CONTROL	NULL
5	NULL
\	NULL
€	NULL
|	NULL
\	NULL
5	NULL
R	NULL
?	NULL

I	NULL
5	NULL
\	NULL
8	NULL
Tf	NULL
mm	NULL
9	NULL
®	NULL
_|	NULL
-E	NULL
TREATED	NULL
&	NULL
0	NULL
Log	NULL
fluorescence	NULL
intensity	NULL
led	NULL
Percent	NULL
antigen	NULL
positive	NULL
cells	NULL
100	NULL
80	NULL
{	NULL
60	NULL
7	NULL
40	NULL
{	NULL
20	NULL
4	NULL
1	NULL
2	NULL
3	NULL
days	NULL
of	NULL
B-estradiol	NULL
treatment	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
surface	NULL
marker	NULL
composition	NULL
induced	NULL
by	NULL
the	NULL
activated	NULL
NF-M-ER	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Surface	NULL
marker	NULL
expression	NULL
of	NULL
NF-M-ER-expressing	NULL
cells	NULL
(	NULL
cl.6	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
cytofluorometric	NULL
analysis	NULL
after	NULL
treatment	NULL
for	NULL
3	NULL
days	NULL
with	NULL
B-estradiol	NULL
(	NULL
150	NULL
nM	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
or	NULL
with	NULL
solvent	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
histidinol	NULL
(	NULL
1	NULL
mg/mi	NULL
)	NULL
and	NULL
recombinant	NULL
cMGF	NULL
.	NULL

Flow	NULL
cytometric	NULL
profiles	NULL
are	NULL
shown	NULL
using	NULL
MEP21	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
,	NULL
MEP26	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
and	NULL
EOS47	NULL
(	NULL
stippled	NULL
line	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NF-M-ER-expressing	NULL
cells	NULL
(	NULL
cl.6	NULL
)	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
cells	NULL
were	NULL
harvested	NULL
daily	NULL
and	NULL
surface	NULL
marker	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
cytofluorometric	NULL
analysis	NULL
and	NULL
plotted	NULL
as	NULL
percentage	NULL
of	NULL
antigen-expressing	NULL
cells	NULL
(	NULL
circles	NULL
:	NULL
MEP21	NULL
;	NULL
triangles	NULL
:	NULL
MEP26	NULL
;	NULL
squares	NULL
:	NULL
EOS47	NULL
)	NULL
.	NULL

expressed	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NF-M	NULL
causes	NULL
cell	NULL
death	NULL
and	NULL
that	NULL
selection	NULL
for	NULL
clones	NULL
that	NULL
have	NULL
lost	NULL
NF-M-ER	NULL
expression	NULL
protects	NULL
them	NULL
from	NULL
estrogen-induced	NULL
cell	NULL
death	NULL
.	NULL

Since	NULL
hematopoietic	NULL
differentiation	NULL
is	NULL
often	NULL
accompanied	NULL
by	NULL
programed	NULL
cell	NULL
death	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
NF-M	NULL
induces	NULL
apoptosis	NULL
.	NULL

First	NULL
,	NULL
the	NULL
integrity	NULL
of	NULL
nuclear	NULL
DNA	NULL
was	NULL
determined	NULL
,	NULL
as	NULL
most	NULL
apoptotic	NULL
cells	NULL
contain	NULL
degraded	NULL
chromosomal	NULL
DNA	NULL
by	NULL
endonuclease	NULL
digestion	NULL
(	NULL
Caron-Leslie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ucker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Barry	NULL
and	NULL
Eastman	NULL
,	NULL
1993	NULL
;	NULL
Peitsch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
can	NULL
be	NULL
visualized	NULL
by	NULL
gel	NULL
electrophoresis	NULL
as	NULL
a	NULL
'DNA	NULL
ladder	NULL
'	NULL
with	NULL
a	NULL
typical	NULL
200	NULL
bp	NULL
periodicity	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
,	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
cellular	NULL
DNA	NULL
from	NULL
two	NULL
NF-M-ER-expressing	NULL
clones	NULL
and	NULL
from	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
before	NULL
and	NULL
after	NULL
treatment	NULL
with	NULL
fB-estradiol	NULL
.	NULL

The	NULL
characteristic	NULL
'ladder	NULL
'	NULL
pattern	NULL
of	NULL
DNA	NULL
(	NULL
Figure	NULL
8A	NULL
)	NULL
was	NULL
observed	NULL
24-36	NULL
h	NULL
after	NULL
estrogen	NULL
activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
protein	NULL
,	NULL
indicating	NULL
that	NULL
death	NULL
had	NULL
occurred	NULL
through	NULL
apoptosis	NULL
.	NULL

Only	NULL
traces	NULL
of	NULL
DNA	NULL
degradation	NULL
were	NULL
found	NULL
in	NULL
untreated	NULL
NF-M-ER-expressing	NULL
cells	NULL
or	NULL
in	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
before	NULL
or	NULL
after	NULL
treatment	NULL
with	NULL
B-estradiol	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
B-estradiol-treated	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
and	NULL
tested	NULL
in	NULL
the	NULL
'TUNEL	NULL
'	NULL
assay	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
DNA	NULL
strand	NULL
breaks	NULL
are	NULL
detected	NULL
by	NULL
treating	NULL
the	NULL
cells	NULL
with	NULL
terminal	NULL
transferase	NULL
and	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-coupled	NULL
dUTP	NULL
which	NULL
is	NULL
subsequently	NULL
visualized	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
(	NULL
Gavrieli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
8B	NULL
and	NULL
Table	NULL
I	NULL
,	NULL
60	NULL
%	NULL
of	NULL
the	NULL
NF-M-ER	NULL
cells	NULL
stained	NULL
positive	NULL
24	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
B-estradiol	NULL
,	NULL
while	NULL
<	NULL
0.5	NULL
%	NULL
positive	NULL
cells	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
untreated	NULL
samples	NULL
or	NULL
in	NULL
the	NULL
parental	NULL
cells	NULL
treated	NULL
with	NULL
B-estradiol	NULL
.	NULL

Finally	NULL
,	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
B-estradiol-treated	NULL
NF-M-ER	NULL
cells	NULL
also	NULL
exhibit	NULL
chromatin	NULL
and	NULL
nuclear	NULL
condensations	NULL
,	NULL
they	NULL
were	NULL
centrifuged	NULL
onto	NULL
slides	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
stained	NULL
with	NULL
4,6-diamidin-2-indole	NULL
dihydrochloride	NULL
(	NULL
DAPI	NULL
)	NULL
.	NULL

As	NULL
6130	NULL
A	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
NF-M	NULL
in	NULL
eosinophils	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
and	NULL
peroxidase	NULL
staining	NULL
and	NULL
immunostaining	NULL
using	NULL
an	NULL
NF-M-specific	NULL
polyclonal	NULL
antiserum	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
fluorescence	NULL
micrograph	NULL
(	NULL
A	NULL
)	NULL
shows	NULL
two	NULL
cells	NULL
expressing	NULL
nuclear	NULL
NF-M	NULL
staining	NULL
.	NULL

The	NULL
bright	NULL
field	NULL
micrograph	NULL
of	NULL
the	NULL
same	NULL
field	NULL
(	NULL
B	NULL
)	NULL
reveals	NULL
one	NULL
of	NULL
them	NULL
as	NULL
an	NULL
eosinophil	NULL
.	NULL

shown	NULL
in	NULL
Figure	NULL
8C	NULL
and	NULL
Table	NULL
I	NULL
,	NULL
49	NULL
%	NULL
of	NULL
the	NULL
NF-M-ER-expressing	NULL
cells	NULL
had	NULL
condensed	NULL
nuclei	NULL
24	NULL
h	NULL
after	NULL
B-estradiol	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
<	NULL
1	NULL
%	NULL
of	NULL
the	NULL
corresponding	NULL
untreated	NULL
cells	NULL
or	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
showed	NULL
similar	NULL
DNA	NULL
con-densations	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
eosinophil	NULL
differentiation	NULL
,	NULL
NF-M	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
programed	NULL
cell	NULL
death	NULL
in	NULL
HD57	NULL
MEP	NULL
cells	NULL
.	NULL

Discussion	NULL
To	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
NF-M	NULL
(	NULL
C/EBPP	NULL
)	NULL
on	NULL
hematopoietic	NULL
differentiation	NULL
,	NULL
we	NULL
used	NULL
HD57	NULL
MEP	NULL
cells	NULL
expressing	NULL
a	NULL
conditional	NULL
NF-M	NULL
derivative	NULL
.	NULL

These	NULL
cells	NULL
possess	NULL
differentiation	NULL
potential	NULL
towards	NULL
myelomonocytic	NULL
,	NULL
eosinophilic	NULL
,	NULL
erythroid	NULL
and	NULL
thrombocytic	NULL
lineages	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
and	NULL
lack	NULL
NF-M	NULL
expression	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
phorbol	NULL
ester	NULL
40	NULL
Percent	NULL
viable	NULL
cells	NULL
20	NULL
Q	NULL
+	NULL
--	NULL
-	NULL
im-	NULL
i-	NULL
--	NULL
-0	NULL
1	NULL
2	NULL
8	NULL
4	NULL
50	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
days	NULL
of	NULL
B-estradiol	NULL
treatment	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Activation	NULL
of	NULL
NF-M-ER	NULL
induces	NULL
cell	NULL
death	NULL
.	NULL

1	NULL
X	NULL
10°	NULL
cells	NULL
from	NULL
two	NULL
NF-M-ER-expressing	NULL
clones	NULL
,	NULL
cl.3	NULL
(	NULL
A	NULL
)	NULL
and	NULL
cl.14	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
from	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
C	NULL
)	NULL
were	NULL
seeded	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
histidinol	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
and	NULL
recombinant	NULL
cMGF	NULL
and	NULL
treated	NULL
with	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
or	NULL
4-hydroxytamoxifen	NULL
(	NULL
40HT	NULL
,	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
5	NULL
days	NULL
.	NULL

Aliquots	NULL
were	NULL
removed	NULL
daily	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
viable	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
staining	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
duplicates	NULL
(	NULL
circles	NULL
:	NULL
without	NULL
hormone	NULL
;	NULL
triangles	NULL
:	NULL
plus	NULL
B-estradiol	NULL
;	NULL
squares	NULL
:	NULL
plus	NULL
4O0HT	NULL
)	NULL
.	NULL

induced	NULL
differentiation	NULL
of	NULL
MEP	NULL
cells	NULL
into	NULL
the	NULL
myeloid	NULL
lineage	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
NF-M	NULL
expression	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
mim-1	NULL
gene	NULL
is	NULL
induced	NULL
rapidly	NULL
after	NULL
-estradiol	NULL
activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
in	NULL
HD57	NULL
MEP	NULL
cells	NULL
.	NULL

This	NULL
gene	NULL
is	NULL
regulated	NULL
directly	NULL
by	NULL
Myb	NULL
and	NULL
C/EBPRB	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
and	NULL
eosinophilic	NULL
lineages	NULL
(	NULL
Ness	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1993	NULL
;	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
chimera	NULL
led	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
eosinophilic	NULL
differentiation	NULL
markers	NULL
,	NULL
the	NULL
surface	NULL
antigen	NULL
EOS47	NULL
and	NULL
eosinophil	NULL
peroxidase	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
eosinophil-specific	NULL
genes	NULL
,	NULL
NF-M	NULL
also	NULL
caused	NULL
down-regulation	NULL
of	NULL
antigens	NULL
characteristic	NULL
for	NULL
the	NULL
early	NULL
progenitor	NULL
stage	NULL
of	NULL
MEP	NULL
cells	NULL
,	NULL
a	NULL
process	NULL
which	NULL
goes	NULL
beyond	NULL
the	NULL
mere	NULL
induction	NULL
of	NULL
target	NULL
genes	NULL
in	NULL
heterologous	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
NF-M	NULL
activation	NULL
causes	NULL
eosinophilic	NULL
lineage	NULL
commitment	NULL
of	NULL
hematopoietic	NULL
precursors	NULL
.	NULL

Originally	NULL
NF-M	NULL
expression	NULL
could	NULL
only	NULL
be	NULL
detected	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
of	NULL
the	NULL
hematopoietic	NULL
system	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
however	NULL
,	NULL
NF-M	NULL
was	NULL
also	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
eosinophilic	NULL
cells	NULL
derived	NULL
from	NULL
a	NULL
myeloblast	NULL
cell	NULL
line	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
GATA-1	NULL
(	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
could	NULL
be	NULL
extended	NULL
to	NULL
normal	NULL
eosinophils	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Since	NULL
eosinophils	NULL
derived	NULL
either	NULL
from	NULL
myelomonocytic	NULL
cells	NULL
or	NULL
from	NULL
MEP	NULL
cells	NULL
showed	NULL
the	NULL
concomitant	NULL
expression	NULL
of	NULL
c-Myb	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
NF-M	NULL
and	NULL
GATA-1	NULL
,	NULL
while	NULL
myelomonocytic	NULL
cells	NULL
lack	NULL
GATA-1	NULL
(	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
balance	NULL
between	NULL
these	NULL
three	NULL
transcription	NULL
factors	NULL
plays	NULL
a	NULL
decisive	NULL
role	NULL
in	NULL
lineage	NULL
determination	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
idea	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
activation	NULL
of	NULL
GATA-1	NULL
represses	NULL
myelomonocytic	NULL
gene	NULL
expression	NULL
(	NULL
Kulessa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
postulate	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
decision	NULL
for	NULL
lineage	NULL
commitment	NULL
of	NULL
MEP	NULL
cells	NULL
(	NULL
and	NULL
possibly	NULL
also	NULL
of	NULL
normal	NULL
progenitor	NULL
cells	NULL
)	NULL
is	NULL
influenced	NULL
by	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NF-M	NULL
(	NULL
C/EBPRB	NULL
)	NULL
and	NULL
GATA-1	NULL
on	NULL
a	NULL
background	NULL
of	NULL
Myb	NULL
expres-sion	NULL
.	NULL

If	NULL
GATA-1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-M	NULL
,	NULL
progenitors	NULL
can	NULL
differentiate	NULL
into	NULL
the	NULL
thrombocytic	NULL
and	NULL
Differentiation	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
C/EBPB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
NF-M.	NULL
(	NULL
A	NULL
)	NULL
Visualization	NULL
of	NULL
fragmented	NULL
DNA	NULL
by	NULL
gel	NULL
electrophoresis	NULL
.	NULL

NF-M-ER	NULL
c1.3	NULL
and	NULL
c1.6	NULL
DNA	NULL
were	NULL
prepared	NULL
after	NULL
36	NULL
h	NULL
of	NULL
B-estradiol	NULL
treatment	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
to	NULL
visualize	NULL
DNA	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
parental	NULL
cells	NULL
,	NULL
without	NULL
hormone	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
parental	NULL
cells	NULL
,	NULL
plus	NULL
B-estradiol	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
NF-M-ER	NULL
cl1.3	NULL
,	NULL
without	NULL
hormone	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
NF-M-ER	NULL
cl.3	NULL
,	NULL
plus	NULL
B-estradiol	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
NF-M-ER	NULL
cl.6	NULL
,	NULL
without	NULL
hormone	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
NF-M-ER	NULL
c1.6	NULL
,	NULL
plus	NULL
-estradiol	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Visualization	NULL
of	NULL
apoptotic	NULL
cells	NULL
by	NULL
the	NULL
TUNEL	NULL
technique	NULL
.	NULL

NF-M-ER	NULL
cl.3	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
24	NULL
h	NULL
and	NULL
pelleted	NULL
by	NULL
cytocentrifugation	NULL
.	NULL

After	NULL
fixation	NULL
and	NULL
permeabilization	NULL
,	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
fluorescein-coupled	NULL
dUTP	NULL
using	NULL
terminal	NULL
transferase	NULL
(	NULL
TUNEL	NULL
reaction	NULL
)	NULL
and	NULL
examined	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

Fluorescent	NULL
nuclei	NULL
indicative	NULL
of	NULL
apoptosis	NULL
are	NULL
marked	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Visualization	NULL
of	NULL
nuclear	NULL
condensations	NULL
by	NULL
DAPI	NULL
staining	NULL
.	NULL

NF-M-ER	NULL
cl.3	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
in	NULL
(	NULL
B	NULL
)	NULL
,	NULL
fixed	NULL
and	NULL
cellular	NULL
DNA	NULL
was	NULL
stained	NULL
with	NULL
DAPI	NULL
.	NULL

The	NULL
fluorescence	NULL
micrograph	NULL
shows	NULL
nuclear	NULL
condensations	NULL
typical	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
indicated	NULL
by	NULL
arrows	NULL
)	NULL
.	NULL

Table	NULL
I.	NULL
Apoptotic	NULL
cells	NULL
revealed	NULL
by	NULL
cytological	NULL
staining	NULL
HD57	NULL
MEP	NULL
cells	NULL
Parental	NULL
NF-M-ER	NULL
B-Estradiol*	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Nuclear	NULL
condensations	NULL
216125	NULL
3/845	NULL
4/7717	NULL
77/57	NULL
by	NULL
DAPI	NULL
staining	NULL
(	NULL
0.3	NULL
)	NULL
(	NULL
0.4	NULL
)	NULL
(	NULL
0.6	NULL
)	NULL
(	NULL
49.0	NULL
)	NULL
Terminal	NULL
transferase	NULL
16/868°	NULL
16/838	NULL
-	NULL
46/821	NULL
289/484	NULL
(	NULL
TUNEL	NULL
)	NULL
assay	NULL
(	NULL
1.8	NULL
(	NULL
1.9	NULL
)	NULL
(	NULL
5.6	NULL
)	NULL
(	NULL
59.7	NULL
)	NULL
``	NULL
Cells	NULL
were	NULL
treated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
B-estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
in	NULL
the	NULL
Eresence	NULL
of	NULL
histidinol	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
and	NULL
recombinant	NULL
cMGF	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
.	NULL

Positive	NULL
cells	NULL
versus	NULL
total	NULL
cell	NULL
counts	NULL
24	NULL
h	NULL
following	NULL
estradiol	NULL
treatment	NULL
.	NULL

Percentage	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

erythroid	NULL
lineages	NULL
.	NULL

However	NULL
,	NULL
when	NULL
NF-M	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
GATA-1	NULL
,	NULL
possibly	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
second	NULL
factor	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
myelomonocytic	NULL
differentiation	NULL
is	NULL
favored	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
factors	NULL
,	NULL
GATA-1	NULL
and	NULL
NF-M	NULL
,	NULL
would	NULL
allow	NULL
differentiation	NULL
towards	NULL
the	NULL
eosinophilic	NULL
lineage	NULL
.	NULL

The	NULL
decisions	NULL
may	NULL
also	NULL
depend	NULL
on	NULL
the	NULL
relative	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
individual	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
earlier	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
phorbol	NULL
ester	NULL
6131	NULL
C.Muller	NULL
et	NULL
al	NULL
.	NULL

induces	NULL
MEP	NULL
cell	NULL
differentiation	NULL
towards	NULL
either	NULL
the	NULL
myelomonocytic	NULL
or	NULL
the	NULL
eosinophilic	NULL
lineage	NULL
,	NULL
depending	NULL
on	NULL
whether	NULL
high	NULL
or	NULL
low	NULL
TPA	NULL
concentrations	NULL
were	NULL
used	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
however	NULL
,	NULL
B-estradiol-induced	NULL
activation	NULL
of	NULL
the	NULL
NF-M-ER	NULL
chimera	NULL
led	NULL
to	NULL
the	NULL
differentiation	NULL
of	NULL
eosinophils	NULL
only	NULL
.	NULL

Failure	NULL
to	NULL
obtain	NULL
myelomonocytic	NULL
cells	NULL
could	NULL
indicate	NULL
that	NULL
is	NULL
not	NULL
as	NULL
efficient	NULL
as	NULL
other	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
such	NULL
as	NULL
C/EBPa	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
immature	NULL
myelomonocytic	NULL
cells	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
C/EBPB	NULL
,	NULL
disappears	NULL
during	NULL
differentiation	NULL
(	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
additional	NULL
transcription	NULL
factors	NULL
are	NULL
missing	NULL
which	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
NF-M	NULL
or	NULL
C/EBP	NULL
to	NULL
sustain	NULL
myelomonocytic	NULL
differentiation	NULL
.	NULL

This	NULL
possibility	NULL
would	NULL
be	NULL
reminiscent	NULL
of	NULL
C/EBPa-induced	NULL
adipocytic	NULL
differentiation	NULL
,	NULL
which	NULL
requires	NULL
another	NULL
adipocyte-specific	NULL
factor	NULL
,	NULL
the	NULL
lipid-activatable	NULL
nuclear	NULL
hormone	NULL
receptor	NULL
PPARy2	NULL
(	NULL
Tontonoz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Since	NULL
C/EBP	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
differentiating	NULL
cells	NULL
of	NULL
several	NULL
tissues	NULL
like	NULL
fat	NULL
,	NULL
liver	NULL
,	NULL
intestine	NULL
,	NULL
skin	NULL
and	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
synergizing	NULL
partner	NULL
proteins	NULL
might	NULL
always	NULL
be	NULL
required	NULL
to	NULL
control	NULL
completion	NULL
of	NULL
the	NULL
C/EBP-induced	NULL
differentiation	NULL
process	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
.	NULL

Another	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
myelomonocytic	NULL
differentiation	NULL
is	NULL
that	NULL
the	NULL
cells	NULL
die	NULL
because	NULL
suitable	NULL
growth	NULL
factors	NULL
are	NULL
missing	NULL
(	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
growth	NULL
,	NULL
survival	NULL
and	NULL
differentiation	NULL
of	NULL
chicken	NULL
-	NULL
myeloblasts/promyelocytes	NULL
depend	NULL
on	NULL
the	NULL
G-CSF/Il-6-related	NULL
chicken	NULL
myelomonocytic	NULL
growth	NULL
factor	NULL
,	NULL
cMGF	NULL
(	NULL
Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cMGF	NULL
,	NULL
cell	NULL
death	NULL
could	NULL
not	NULL
be	NULL
inhibited	NULL
.	NULL

This	NULL
could	NULL
reflect	NULL
either	NULL
the	NULL
absence	NULL
of	NULL
cMGF	NULL
receptor	NULL
in	NULL
estrogen-treated	NULL
NF-M-ER-expressing	NULL
cells	NULL
or	NULL
the	NULL
requirement	NULL
for	NULL
yet	NULL
another	NULL
growth	NULL
factor	NULL
.	NULL

We	NULL
tried	NULL
to	NULL
circumvent	NULL
the	NULL
supposed	NULL
factor	NULL
dependence	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
either	NULL
the	NULL
mammalian	NULL
erythropoietin	NULL
receptor	NULL
or	NULL
the	NULL
G-CSF	NULL
receptor	NULL
,	NULL
which	NULL
are	NULL
functional	NULL
in	NULL
chicken	NULL
cells	NULL
(	NULL
Steinlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
C.Miiller	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
erythropoietin	NULL
nor	NULL
G-CSF	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
prevented	NULL
their	NULL
hormone-induced	NULL
death	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
NF-M-ER	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
myelomonocytic	NULL
cells	NULL
might	NULL
also	NULL
have	NULL
more	NULL
trivial	NULL
reasons	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
NF-M-ER	NULL
clones	NULL
partially	NULL
or	NULL
completely	NULL
lost	NULL
their	NULL
capacitiy	NULL
to	NULL
differentiate	NULL
when	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
T.Graf	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
this	NULL
is	NULL
also	NULL
seen	NULL
with	NULL
most	NULL
HD57-derived	NULL
subclones	NULL
suggests	NULL
that	NULL
our	NULL
culture	NULL
conditions	NULL
favor	NULL
the	NULL
outgrowth	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
differentiate	NULL
.	NULL

Several	NULL
transcription	NULL
factors	NULL
normally	NULL
involved	NULL
in	NULL
driving	NULL
cells	NULL
into	NULL
proliferation	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
apoptosis	NULL
when	NULL
expressed	NULL
inappropriately	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

This	NULL
has	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
programed	NULL
cell	NULL
death	NULL
occurs	NULL
when	NULL
quiescent	NULL
cells	NULL
receive	NULL
an	NULL
incomplete	NULL
set	NULL
of	NULL
signals	NULL
required	NULL
for	NULL
proliferation	NULL
(	NULL
Evan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Wu	NULL
and	NULL
Levine	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
an	NULL
example	NULL
for	NULL
the	NULL
converse	NULL
situation	NULL
,	NULL
namely	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
cell	NULL
differentiation	NULL
that	NULL
can	NULL
act	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
apoptosis	NULL
when	NULL
activated	NULL
in	NULL
multiplying	NULL
cells	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
apoptosis	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
might	NULL
be	NULL
provoked	NULL
not	NULL
only	NULL
by	NULL
incomplete	NULL
proliferation	NULL
commands	NULL
but	NULL
by	NULL
incomplete	NULL
differentiation	NULL
commands	NULL
as	NULL
well	NULL
.	NULL

Whether	NULL
or	NULL
not	NULL
NF-M-induced	NULL
differentiation	NULL
and	NULL
6132	NULL
apoptosis	NULL
represent	NULL
alternative	NULL
fates	NULL
of	NULL
MEP	NULL
cells	NULL
is	NULL
an	NULL
interesting	NULL
question	NULL
which	NULL
remains	NULL
to	NULL
be	NULL
studied	NULL
.	NULL

Is	NULL
the	NULL
observed	NULL
apoptotic	NULL
activity	NULL
of	NULL
NF-M	NULL
relevant	NULL
for	NULL
the	NULL
hematopoietic	NULL
differentiation	NULL
process	NULL
?	NULL

Several	NULL
observations	NULL
support	NULL
this	NULL
possibility	NULL
.	NULL

Thus	NULL
,	NULL
phorbol	NULL
ester-induced	NULL
MEP	NULL
differentiation	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
apop-topic	NULL
death	NULL
of	NULL
a	NULL
significant	NULL
but	NULL
variable	NULL
proportion	NULL
of	NULL
the	NULL
cell	NULL
population	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
T.Graf	NULL
,	NULL
preliminary	NULL
results	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
v-myb-transformed	NULL
myeloblasts	NULL
into	NULL
macrophages	NULL
also	NULL
causes	NULL
extensive	NULL
cell	NULL
death	NULL
by	NULL
apoptosis	NULL
(	NULL
Smarda	NULL
and	NULL
Lipsick	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
mediates	NULL
phorbol	NULL
ester-induced	NULL
apoptosis	NULL
in	NULL
activated	NULL
human	NULL
macrophages	NULL
,	NULL
a	NULL
process	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
growth	NULL
factors	NULL
(	NULL
Munn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Since	NULL
PKC	NULL
activation	NULL
strongly	NULL
enhances	NULL
C/EBPB-NF-M	NULL
transcription	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Trautwein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
PKC-mediated	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
might	NULL
occur	NULL
via	NULL
activation	NULL
of	NULL
C/EBPRB-NF-M.	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
situation	NULL
in	NULL
HD57	NULL
MEP	NULL
cells	NULL
might	NULL
be	NULL
different	NULL
,	NULL
as	NULL
apoptosis	NULL
and	NULL
gene	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
chimeric	NULL
NF-M-ER	NULL
protein	NULL
occur	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
activated	NULL
PKC	NULL
.	NULL

However	NULL
,	NULL
this	NULL
discrepancy	NULL
might	NULL
be	NULL
explained	NULL
by	NULL
failure	NULL
of	NULL
proper	NULL
regulation	NULL
of	NULL
NF-M	NULL
in	NULL
the	NULL
ER	NULL
context	NULL
following	NULL
activation	NULL
by	NULL
fB-estradiol	NULL
.	NULL

Since	NULL
activation	NULL
of	NULL
NF-M	NULL
by	NULL
kinases	NULL
is	NULL
due	NULL
to	NULL
derepression	NULL
,	NULL
probably	NULL
involving	NULL
a	NULL
conformational	NULL
change	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
hormone	NULL
binding	NULL
to	NULL
the	NULL
chimeric	NULL
protein	NULL
might	NULL
cause	NULL
a	NULL
similar	NULL
structural	NULL
alteration	NULL
in	NULL
NF-M.	NULL
As	NULL
NF-M	NULL
exhibits	NULL
a	NULL
highly	NULL
modular	NULL
structure	NULL
,	NULL
it	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
know	NULL
which	NULL
domains	NULL
are	NULL
necessary	NULL
for	NULL
its	NULL
capacity	NULL
to	NULL
induce	NULL
apoptosis	NULL
.	NULL

Preliminary	NULL
evidence	NULL
based	NULL
on	NULL
mutational	NULL
analysis	NULL
indicates	NULL
that	NULL
apoptosis	NULL
is	NULL
critically	NULL
dependent	NULL
on	NULL
its	NULL
transactivation	NULL
domains	NULL
(	NULL
Kowenz-Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
implying	NULL
that	NULL
one	NULL
or	NULL
more	NULL
genes	NULL
have	NULL
to	NULL
be	NULL
induced	NULL
to	NULL
mediate	NULL
cell	NULL
killing	NULL
.	NULL

It	NULL
will	NULL
be	NULL
important	NULL
to	NULL
identify	NULL
these	NULL
genes	NULL
which	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
vital	NULL
role	NULL
in	NULL
hematopoietic	NULL
homeostasis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
growth	NULL
inhibition	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
following	NULL
NF-M-CEBPB	NULL
activation	NULL
is	NULL
based	NULL
on	NULL
the	NULL
same	NULL
structural	NULL
features	NULL
of	NULL
NF-M	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
or	NULL
whether	NULL
these	NULL
functions	NULL
exhibit	NULL
cell	NULL
type	NULL
specificity	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Vector	NULL
construction	NULL
An	NULL
NF-M	NULL
HindIII-BamHI	NULL
fragment	NULL
which	NULL
contains	NULL
the	NULL
complete	NULL
coding	NULL
region	NULL
and	NULL
translational	NULL
initiation	NULL
site	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
was	NULL
fused	NULL
at	NULL
its	NULL
carboxyl-terminus	NULL
in-frame	NULL
to	NULL
a	NULL
BamHI-BamHI	NULL
fragment	NULL
which	NULL
contained	NULL
the	NULL
hormone	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
(	NULL
amino	NULL
acids	NULL
282-595	NULL
)	NULL
(	NULL
Greene	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
and	NULL
the	NULL
polyadenylation	NULL
signal	NULL
of	NULL
the	NULL
herpes	NULL
virus	NULL
thymidine	NULL
kinase	NULL
gene	NULL
,	NULL
both	NULL
derived	NULL
from	NULL
the	NULL
C/EBPO®-ER	NULL
expression	NULL
vector	NULL
(	NULL
Umek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
construct	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
#	NULL
321	NULL
(	NULL
Buerstedde	NULL
and	NULL
Takeda	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
where	NULL
it	NULL
was	NULL
transcibed	NULL
from	NULL
the	NULL
chicken	NULL
B-actin	NULL
promoter	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
vector	NULL
carried	NULL
a	NULL
histidinol	NULL
resistance	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Cloning	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
and	NULL
the	NULL
function	NULL
and	NULL
inducibility	NULL
of	NULL
the	NULL
construct	NULL
was	NULL
tested	NULL
by	NULL
transient	NULL
transfection	NULL
experiments	NULL
using	NULL
cMGF	NULL
promoter-luciferase	NULL
reporter	NULL
constructs	NULL
(	NULL
Sterneck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
tissue	NULL
culture	NULL
Cells	NULL
were	NULL
incubated	NULL
under	NULL
tissue	NULL
culture	NULL
conditions	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
39°C	NULL
.	NULL

HDS7	NULL
MEP	NULL
cells	NULL
were	NULL
propagated	NULL
in	NULL
phenol	NULL
red-free	NULL
medium-mix	NULL
[	NULL
350	NULL
ml	NULL
of	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
without	NULL
phenol	NULL
red	NULL
(	NULL
Gibco	NULL
)	NULL
,	NULL
50	NULL
ml	NULL
of	NULL
bidest	NULL
,	NULL
50	NULL
ml	NULL
of	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
12.5	NULL
ml	NULL
of	NULL
chicken	NULL
serum	NULL
(	NULL
not	NULL
heat-treated	NULL
)	NULL
,	NULL
13	NULL
ml	NULL
of	NULL
7.5	NULL
%	NULL
NaHCO	NULL
,	NULL
1.9	NULL
m	NULL
!	NULL

of	NULL
15	NULL
mg/ml	NULL
conalbumin	NULL
,	NULL
275	NULL
pl	NULL
of	NULL
1.7	NULL
mg/ml	NULL
insulin	NULL
,	NULL
800	NULL
ul	NULL
of	NULL
50	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
9	NULL
ml	NULL
of	NULL
20	NULL
%	NULL
glucose	NULL
solution	NULL
and	NULL
the	NULL
standard	NULL
complement	NULL
of	NULL
antibiotics	NULL
]	NULL
(	NULL
Graf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
activate	NULL
the	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
,	NULL
B-estradiol	NULL
or	NULL
4-0HT	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
in	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
uM	NULL
and	NULL
the	NULL
medium	NULL
was	NULL
supplemented	NULL
with	NULL
200	NULL
U/ml	NULL
of	NULL
recombinant	NULL
cMGF	NULL
(	NULL
Leutz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
inhibit	NULL
protein	NULL
biosynthesis	NULL
,	NULL
cycloheximide	NULL
was	NULL
added	NULL
at	NULL
50	NULL
pg/ml	NULL
final	NULL
concentration	NULL
.	NULL

Transient	NULL
transfection	NULL
The	NULL
erythroblast	NULL
cell	NULL
line	NULL
HD3	NULL
(	NULL
v-erbA	NULL
,	NULL
v-erbB-transformed	NULL
;	NULL
Beug	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
was	NULL
transfected	NULL
by	NULL
a	NULL
DEAE-dextran	NULL
procedure	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
by	NULL
Sterneck	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1992b	NULL
)	NULL
.	NULL

The	NULL
effector	NULL
plasmid	NULL
DNA	NULL
concentration	NULL
was	NULL
0.6	NULL
and	NULL
1	NULL
ug/ml	NULL
with	NULL
the	NULL
luciferase	NULL
reporters	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
0.3	NULL
mg/ml	NULL
DEAE-dextran	NULL
in	NULL
STBS	NULL
solution	NULL
(	NULL
Ausubel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
B-estradiol	NULL
in	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
uM	NULL
or	NULL
with	NULL
solvent	NULL
,	NULL
harvested	NULL
after	NULL
40	NULL
h	NULL
and	NULL
lysed	NULL
in	NULL
0.1	NULL
M	NULL
potassium	NULL
phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
7.8	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
and	NULL
30	NULL
pl	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
de	NULL
Wet	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Sterneck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

Assays	NULL
were	NULL
done	NULL
in	NULL
duplicate	NULL
.	NULL

Stable	NULL
transfection	NULL
Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
at	NULL
1	NULL
X	NULL
10	NULL
cells/45	NULL
ul	NULL
.	NULL

The	NULL
plasmid	NULL
DNA	NULL
was	NULL
purified	NULL
twice	NULL
on	NULL
CsCl	NULL
gradients	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
in	NULL
a	NULL
concentration	NULL
of	NULL
I	NULL
ug/ul	NULL
.	NULL

For	NULL
each	NULL
electroporation	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
DNA	NULL
(	NULL
5	NULL
ul	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
1X	NULL
10	NULL
``	NULL
cells	NULL
(	NULL
45	NULL
Jl	NULL
)	NULL
and	NULL
transferred	NULL
into	NULL
an	NULL
electroporation	NULL
cuvette	NULL
with	NULL
an	NULL
electrode	NULL
gap	NULL
of	NULL
0.4	NULL
cm	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Electroporation	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
capacity	NULL
of	NULL
250	NULL
uF	NULL
and	NULL
a	NULL
voltage	NULL
of	NULL
200	NULL
V	NULL
which	NULL
resulted	NULL
in	NULL
a	NULL
time	NULL
constant	NULL
of	NULL
12-15	NULL
ms	NULL
(	NULL
Gene	NULL
Pulser	NULL
Apparatus	NULL
,	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Electro-porated	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
seeded	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium-mix	NULL
without	NULL
phenol	NULL
red	NULL
.	NULL

After	NULL
1-2	NULL
days	NULL
,	NULL
different	NULL
concentrations	NULL
of	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
semi-solid	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
methylcellulose	NULL
(	NULL
Methocel	NULL
,	NULL
Fulka	NULL
)	NULL
in	NULL
phenol	NULL
red-free	NULL
medium-mix	NULL
with	NULL
a	NULL
histidinol	NULL
concentration	NULL
of	NULL
3	NULL
mg/ml	NULL
.	NULL

Fourteen	NULL
days	NULL
later	NULL
histidinol-resistant	NULL
colonies	NULL
were	NULL
isolated	NULL
and	NULL
transferred	NULL
to	NULL
500	NULL
ul	NULL
of	NULL
fresh	NULL
medium-mix	NULL
without	NULL
phenol	NULL
red	NULL
which	NULL
contained	NULL
1	NULL
mg/ml	NULL
histidinol	NULL
.	NULL

Resistant	NULL
clones	NULL
were	NULL
propagated	NULL
and	NULL
examined	NULL
for	NULL
NF-M-ER	NULL
fusion	NULL
protein	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Western	NULL
blotting	NULL
was	NULL
performed	NULL
with	NULL
total	NULL
cell	NULL
lysates	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
0.5	NULL
M	NULL
NaOH	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
then	NULL
neutralized	NULL
with	NULL
0.5	NULL
M	NULL
HCI	NULL
and	NULL
mixed	NULL
with	NULL
6X	NULL
SDS	NULL
loading	NULL
buffer	NULL
.	NULL

An	NULL
equivalent	NULL
of	NULL
2.5	NULL
%	NULL
10°	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
reducing	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
proteins	NULL
were	NULL
subsequently	NULL
electrophoretically	NULL
transferred	NULL
onto	NULL
a	NULL
membrane	NULL
(	NULL
Millipore	NULL
,	NULL
PVDF	NULL
membrane	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
in	NULL
TBST	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
.	NULL

50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.4	NULL
and	NULL
0.02	NULL
%	NULL
v/v	NULL
Tween-20	NULL
)	NULL
for	NULL
2	NULL
h	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
trpE-NF-M	NULL
(	NULL
Katz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
diluted	NULL
1:2000	NULL
in	NULL
blocking	NULL
solution	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-coupled	NULL
second	NULL
antibody	NULL
(	NULL
Bio-Rad	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
blots	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
and	NULL
immunoreactivity	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
chemoluminescence	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
International	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
prepared	NULL
using	NULL
a	NULL
guanidinium	NULL
isothiocyanate	NULL
method	NULL
(	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

The	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
fraction	NULL
was	NULL
isolated	NULL
by	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
coupled	NULL
to	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
Hybond	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
UV	NULL
cross-linked	NULL
and	NULL
backed	NULL
at	NULL
80°C	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
blots	NULL
were	NULL
probed	NULL
in	NULL
QuickHyb	NULL
hybridization	NULL
solution	NULL
(	NULL
Stratagene	NULL
)	NULL
at	NULL
65°C	NULL
for	NULL
3	NULL
h	NULL
with	NULL
appropriate	NULL
random	NULL
*°P-labeled	NULL
(	NULL
Pharmacia	NULL
,	NULL
Amersham	NULL
)	NULL
DNA	NULL
fragments	NULL
.	NULL

The	NULL
restriction	NULL
fragments	NULL
used	NULL
as	NULL
probes	NULL
for	NULL
GAPDH	NULL
and	NULL
mim-1	NULL
have	NULL
been	NULL
described	NULL
earlier	NULL
(	NULL
Ness	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Dugaiczyk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
hybridization	NULL
filters	NULL
were	NULL
washed	NULL
twice	NULL
for	NULL
15	NULL
min	NULL
with	NULL
1X	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
twice	NULL
with	NULL
0.5	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
60°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-	NULL
OMAT-AR	NULL
X-ray	NULL
films	NULL
or	NULL
processed	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
(	NULL
Fuji	NULL
)	NULL
.	NULL

Cytofluorometric	NULL
analysis	NULL
The	NULL
MEP-specific	NULL
monoclonal	NULL
antibodies	NULL
MEP21	NULL
and	NULL
MEP26	NULL
and	NULL
the	NULL
eosinophilic-specific	NULL
monoclonal	NULL
antibody	NULL
EOS47	NULL
have	NULL
been	NULL
described	NULL
Differentiation	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
C/EBPB	NULL
earlier	NULL
(	NULL
McNagny	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Cytofluorometric	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
antibodies	NULL
.	NULL

The	NULL
second	NULL
antibody	NULL
alone	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Antigen-positive	NULL
cells	NULL
,	NULL
negative	NULL
for	NULL
propidium	NULL
iodide	NULL
uptake	NULL
,	NULL
were	NULL
evaluated	NULL
using	NULL
the	NULL
Becton	NULL
Dickinson	NULL
FACScan	NULL
cytometer	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
NF-M	NULL
expression	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
3.7	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
lysed	NULL
with	NULL
0.05	NULL
%	NULL
NP-40	NULL
and	NULL
stained	NULL
with	NULL
a	NULL
polyclonal	NULL
NF-M-specific	NULL
antiserum	NULL
.	NULL

As	NULL
second	NULL
antibodies	NULL
,	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
were	NULL
used	NULL
.	NULL

Peroxidase	NULL
staining	NULL
Cells	NULL
were	NULL
suspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
medium	NULL
to	NULL
which	NULL
20	NULL
pil	NULL
of	NULL
peroxidase	NULL
reagent	NULL
was	NULL
added	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Peroxidase-positive	NULL
cells	NULL
stained	NULL
dark	NULL
brown	NULL
.	NULL

Determination	NULL
of	NULL
cell	NULL
viability	NULL
Cells	NULL
(	NULL
1X10°	NULL
)	NULL
were	NULL
seeded	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
phenol	NULL
red-free	NULL
medium-mix	NULL
containing	NULL
1	NULL
mg/ml	NULL
histidinol	NULL
and	NULL
200	NULL
U	NULL
of	NULL
recombinant	NULL
cMGF	NULL
.	NULL

B-Estradiol	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
or	NULL
the	NULL
solvent	NULL
alone	NULL
in	NULL
control	NULL
experiments	NULL
was	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Aliquots	NULL
(	NULL
50	NULL
pl	NULL
)	NULL
from	NULL
the	NULL
cultures	NULL
were	NULL
taken	NULL
daily	NULL
and	NULL
mixed	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
concentrated	NULL
trypan	NULL
blue	NULL
stain	NULL
solution	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

The	NULL
total	NULL
cell	NULL
number	NULL
and	NULL
the	NULL
number	NULL
of	NULL
dead	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
microscopic	NULL
evaluation	NULL
using	NULL
a	NULL
Neubauer	NULL
counting	NULL
chamber	NULL
.	NULL

Alternatively	NULL
,	NULL
cells	NULL
were	NULL
immobilized	NULL
on	NULL
a	NULL
microscopy	NULL
glass	NULL
slide	NULL
by	NULL
cytocentrifugation	NULL
,	NULL
incubated	NULL
with	NULL
DAPI	NULL
solution	NULL
(	NULL
100	NULL
ug	NULL
DAPI/ml	NULL
methanol	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
analyzed	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

To	NULL
perform	NULL
the	NULL
TUNEL	NULL
assay	NULL
,	NULL
cells	NULL
were	NULL
immobilized	NULL
by	NULL
cytocentri-fugation	NULL
and	NULL
fixed	NULL
with	NULL
3.7	NULL
%	NULL
paraformaldehyde	NULL
solution	NULL
in	NULL
PBS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

They	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
permeabilized	NULL
in	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
citrate	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
TUNEL	NULL
reaction	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
in	NULL
a	NULL
moist	NULL
chamber	NULL
with	NULL
0.3	NULL
nmol	NULL
of	NULL
FITC-12-dUTP	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
3	NULL
nmol	NULL
of	NULL
dATP	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
25	NULL
mM	NULL
CoCl	NULL
;	NULL
,	NULL
,	NULL
25	NULL
U	NULL
of	NULL
terminal	NULL
transferase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
and	NULL
TdT	NULL
buffer	NULL
(	NULL
30	NULL
mM	NULL
Tris	NULL
pH	NULL
7.2	NULL
,	NULL
140	NULL
mM	NULL
sodium	NULL
cacodylate	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
pul	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
2	NULL
pl	NULL
of	NULL
0.5	NULL
M	NULL
EDTA	NULL
.	NULL

Slides	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
analyzed	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

DNA	NULL
ladder	NULL
assay	NULL
Cells	NULL
(	NULL
2	NULL
10°	NULL
)	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
140	NULL
mM	NULL
sodium	NULL
chloride	NULL
,	NULL
20	NULL
mM	NULL
EDTA	NULL
and	NULL
incubated	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
200	NULL
mM	NULL
Tris	NULL
pH	NULL
8.3	NULL
,	NULL
100	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
ug/ml	NULL
proteinase	NULL
K	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
DNA	NULL
was	NULL
extracted	NULL
by	NULL
adding	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
phenol	NULL
followed	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
aqueous	NULL
phase	NULL
was	NULL
dialyzed	NULL
overnight	NULL
against	NULL
10	NULL
mM	NULL
Tris	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

Then	NULL
EDTA	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
25	NULL
mM	NULL
and	NULL
the	NULL
DNA	NULL
solution	NULL
was	NULL
incubated	NULL
with	NULL
RNase	NULL
A	NULL
(	NULL
50	NULL
ug/mi	NULL
)	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
proteinase	NULL
K	NULL
(	NULL
120	NULL
ug/ml	NULL
)	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
phenol-chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
,	NULL
the	NULL
DNA	NULL
pellet	NULL
was	NULL
gently	NULL
resuspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
TE	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
DNA	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
EtBr	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Steven	NULL
McKnight	NULL
and	NULL
Robert	NULL
Umek	NULL
for	NULL
providing	NULL
a	NULL
ER	NULL
plasmid	NULL
and	NULL
Jean-Marie	NULL
Buerstedde	NULL
for	NULL
providing	NULL
the	NULL
#	NULL
321	NULL
expression	NULL
vector	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Martin	NULL
Eilers	NULL
for	NULL
supplying	NULL
reagents	NULL
and	NULL
technical	NULL
tips	NULL
and	NULL
Geraldine	NULL
Twamley	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
Akira.S	NULL
.	NULL

and	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

/mmunol	NULL
Rev	NULL
.	NULL

,	NULL
127	NULL
,	NULL
25-50	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Isshiki.H	NULL
.	NULL

,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Tanabe	NULL
,	NULL
.0.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
1897-1906	NULL
.	NULL

Ausubel	NULL
,	NULL
FM..	NULL
Brent.R	NULL
.	NULL

,	NULL
Kingston	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Moore	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Seidman	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Smith.J.A	NULL
.	NULL

and	NULL
Struhl.K	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley	NULL
Interscience	NULL
.	NULL

Barry	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
Eastman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Identification	NULL
of	NULL
deoxyribonuclease	NULL
11	NULL
as	NULL
an	NULL
endonuclease	NULL
involved	NULL
in	NULL
apoptosis	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

,	NULL
300	NULL
,	NULL
440-450	NULL
.	NULL

Berry.M..	NULL
Metzger.D	NULL
.	NULL

and	NULL
Chambon	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Role	NULL
of	NULL
two	NULL
activating	NULL
6133	NULL
C.Muller	NULL
et	NULL
al	NULL
.	NULL

domains	NULL
of	NULL
the	NULL
estrogen	NULL
receptor	NULL
in	NULL
the	NULL
cell-type	NULL
and	NULL
promotor-context	NULL
dependent	NULL
agonistic	NULL
activity	NULL
of	NULL
the	NULL
anti-oestrogen	NULL
4-hydroxytamoxifen	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
2811-2818	NULL
.	NULL

Beug.H	NULL
.	NULL

,	NULL
v.Kirchbach	NULL
,	NULL
A.	NULL
,	NULL
Déderlein	NULL
,	NULL
G.	NULL
,	NULL
Conscience	NULL
,	NULL
J.-F.	NULL
and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Chicken	NULL
hematopoietic	NULL
cells	NULL
transformed	NULL
by	NULL
seven	NULL
strains	NULL
of	NULL
defective	NULL
avian	NULL
leukemia	NULL
viruses	NULL
display	NULL
three	NULL
distinct	NULL
phenotypes	NULL
of	NULL
differentiation	NULL
.	NULL

Cell	NULL
,	NULL
18	NULL
,	NULL
375-390	NULL
.	NULL

Brune	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Spitznagel	NULL
,	NULL
J.K	NULL
.	NULL

(	NULL
1973	NULL
)	NULL
Peroxidase	NULL
less	NULL
chicken	NULL
leukocytes	NULL
:	NULL
isolation	NULL
and	NULL
characterisation	NULL
of	NULL
antibacterial	NULL
granules	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

,	NULL
127	NULL
,	NULL
84-94	NULL
.	NULL

Buck.M	NULL
.	NULL

,	NULL
Turler	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Chojkier	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
LAP	NULL
(	NULL
NF-IL6	NULL
)	NULL
,	NULL
a	NULL
tissue-specific	NULL
transcriptional	NULL
activator	NULL
,	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
hepatoma	NULL
cell	NULL
proliferation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
851-860	NULL
.	NULL

Buerstedde	NULL
,	NULL
J.-M.	NULL
and	NULL
Takeda	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Increased	NULL
ratio	NULL
of	NULL
targeted	NULL
to	NULL
random	NULL
integration	NULL
after	NULL
transfection	NULL
of	NULL
chicken	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
,	NULL
67	NULL
,	NULL
179-188	NULL
.	NULL

Burk	NULL
,	NULL
O.	NULL
,	NULL
Mink	NULL
,	NULL
S.	NULL
,	NULL
Ringwald	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Klempnaur	NULL
,	NULL
K.H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Synergistic	NULL
activation	NULL
of	NULL
the	NULL
chicken	NULL
mim-1	NULL
gene	NULL
by	NULL
v-Myb	NULL
and	NULL
C/EBP	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
2027-2038	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
Umek	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
1538-1552	NULL
.	NULL

Caron-Leslie	NULL
,	NULL
L.M	NULL
.	NULL

,	NULL
Schwarzman	NULL
,	NULL
R.A.	NULL
,	NULL
Gaido	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Compton	NULL
,	NULL
M.M	NULL
.	NULL

and	NULL
Cidlowski	NULL
,	NULL
J.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Identification	NULL
-	NULL
and	NULL
|	NULL
characterization	NULL
-	NULL
of	NULL
glucocorticoid-regulated	NULL
nuclease	NULL
(	NULL
s	NULL
)	NULL
in	NULL
lymphoid	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
40	NULL
,	NULL
661-671	NULL
.	NULL

Catelli	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Binart	NULL
,	NULL
N.	NULL
,	NULL
Jung-Testas	NULL
,	NULL
L	NULL
,	NULL
Renoir	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Beaulieu	NULL
E.-E.	NULL
,	NULL
Feramisco	NULL
,	NULL
J.-R.	NULL
and	NULL
Welch	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
The	NULL
common	NULL
90-kd	NULL
protein	NULL
component	NULL
of	NULL
non-transformed	NULL
'8s	NULL
'	NULL
steroid	NULL
receptors	NULL
is	NULL
a	NULL
heat-shock	NULL
protein	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
4	NULL
,	NULL
3131-3135	NULL
.	NULL

Chomezynski	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Sacchi	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
-	NULL
by	NULL
-	NULL
acid	NULL
-	NULL
guanidinium	NULL
-	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
162	NULL
,	NULL
156-159	NULL
.	NULL

Christy	NULL
,	NULL
R.J.	NULL
,	NULL
Yang	NULL
.	NULL

Ntambi	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Geiman	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
Landschulz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Friedman	NULL
,	NULL
A.D.	NULL
,	NULL
Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Kelly	NULL
,	NULL
T.J	NULL
.	NULL

and	NULL
Lane	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Differentiation-induced	NULL
gene	NULL
expression	NULL
in	NULL
3T3-L1	NULL
preadipocytes	NULL
:	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
interacts	NULL
with	NULL
and	NULL
activates	NULL
the	NULL
promoters	NULL
of	NULL
two	NULL
adipocyte-specific	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
1323-1335	NULL
.	NULL

deWet	NULL
,	NULL
J.R.	NULL
,	NULL
Wood.K.V	NULL
.	NULL

,	NULL
DeLuca	NULL
,	NULL
M.	NULL
,	NULL
Helsinki	NULL
,	NULL
D.R	NULL
.	NULL

and	NULL
Subramani	NULL
,	NULL
$	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
725-737	NULL
.	NULL

Dugaiczyk	NULL
,	NULL
A.	NULL
,	NULL
Haron	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Stone	NULL
,	NULL
E.M.	NULL
,	NULL
Dennison,0.E	NULL
.	NULL

,	NULL
Rothblum	NULL
,	NULL
K.N	NULL
.	NULL

and	NULL
Schwartz	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Cloning	NULL
and	NULL
sequencing	NULL
of	NULL
a	NULL
deoxy-ribonucleic	NULL
acid	NULL
copy	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
from	NULL
chicken	NULL
muscle	NULL
.	NULL

Biochemistry	NULL
,	NULL
22	NULL
,	NULL
1605-1613	NULL
.	NULL

Evan	NULL
,	NULL
G.L	NULL
.	NULL

,	NULL
Wyllie.A.H	NULL
.	NULL

,	NULL
Gilbert	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
_	NULL
Littlewood	NULL
,	NULL
T.D	NULL
.	NULL

,	NULL
-	NULL
Land	NULL
,	NULL
H.	NULL
,	NULL
Brooks	NULL
,	NULL
M.	NULL
,	NULL
Waters	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Penn	NULL
,	NULL
LZ	NULL
.	NULL

and	NULL
Hancock	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
fibroblasts	NULL
by	NULL
c-myc	NULL
protein	NULL
.	NULL

Cell	NULL
,	NULL
69	NULL
,	NULL
119-128	NULL
.	NULL

Frampton	NULL
,	NULL
J.	NULL
,	NULL
Walker	NULL
,	NULL
M.	NULL
,	NULL
Plumb	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Harrison	NULL
,	NULL
PR	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Synergy	NULL
between	NULL
the	NULL
NF-El	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
and	NULL
the	NULL
CACCC	NULL
factor	NULL
in	NULL
the	NULL
erythroid-specific	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
3838-3842	NULL
.	NULL

Frampton	NULL
,	NULL
J.	NULL
,	NULL
McNagy.K	NULL
.	NULL

,	NULL
Sieweke	NULL
,	NULL
M.	NULL
,	NULL
Philipp	NULL
,	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Graf.T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
v-Myb	NULL
DNA	NULL
binding	NULL
is	NULL
required	NULL
to	NULL
block	NULL
thrombocytic	NULL
differentiation	NULL
of	NULL
Myb-Ets-transformed	NULL
multipotent	NULL
haematopoietic	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
2866-2875	NULL
.	NULL

Freytag	NULL
,	NULL
S.0	NULL
.	NULL

and	NULL
Geddes	NULL
,	NULL
T.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Reciprocal	NULL
regulation	NULL
of	NULL
adipogenesis	NULL
by	NULL
Myc	NULL
and	NULL
C/EBP	NULL
alpha	NULL
.	NULL

Science	NULL
,	NULL
256	NULL
,	NULL
379-382	NULL
.	NULL

Freytag	NULL
,	NULL
S.0	NULL
.	NULL

,	NULL
Paielli	NULL
,	NULL
D.L	NULL
.	NULL

and	NULL
Gilbert	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Ectopic	NULL
expression	NULL
of	NULL
the	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
a	NULL
promotes	NULL
the	NULL
adipogenic	NULL
program	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
mouse	NULL
fibroblastic	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
1654-1663	NULL
.	NULL

Gavrieli	NULL
,	NULL
Y.	NULL
,	NULL
Sherman	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Ben-Sasson	NULL
,	NULL
S.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Identification	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
sit	NULL
via	NULL
specific	NULL
labeling	NULL
of	NULL
nuclear	NULL
DNA	NULL
fragmentation	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
119	NULL
,	NULL
493-501	NULL
.	NULL

Graf	NULL
,	NULL
T.	NULL
,	NULL
McNagny.K	NULL
.	NULL

,	NULL
Brady	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Frampton	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Chicken	NULL
'erythroid	NULL
'	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
Gag-Myb-Ets-encoding	NULL
E26	NULL
leukemia	NULL
virus	NULL
are	NULL
multipotent	NULL
.	NULL

Cell	NULL
,	NULL
70	NULL
,	NULL
201-213	NULL
.	NULL

Greene	NULL
,	NULL
G.L	NULL
.	NULL

,	NULL
Gilna	NULL
,	NULL
P.	NULL
,	NULL
Waterfield	NULL
,	NULL
M.	NULL
,	NULL
Baker	NULL
,	NULL
A.	NULL
,	NULL
Hort	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Shine.J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Sequence	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
estrogen	NULL
receptor	NULL
complementary	NULL
DNA	NULL
.	NULL

Science	NULL
,	NULL
231	NULL
,	NULL
1150-1154	NULL
.	NULL

Herrera	NULL
,	NULL
R.	NULL
,	NULL
Ro	NULL
,	NULL
H.S	NULL
.	NULL

,	NULL
Robinson	NULL
,	NULL
G.	NULL
$	NULL
.	NULL

,	NULL
Xanthopoulos	NULL
,	NULL
K.G	NULL
.	NULL

and	NULL
Spiegelman	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
A	NULL
direct	NULL
role	NULL
for	NULL
C/EBP	NULL
and	NULL
the	NULL
AP-I-binding	NULL
site	NULL
in	NULL
gene	NULL
expression	NULL
linked	NULL
to	NULL
adipocyte	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
5331-5339	NULL
.	NULL

6134	NULL
Juan	NULL
,	NULL
T.S	NULL
.	NULL

,	NULL
Wilson	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
Wilde	NULL
,	NULL
M.D	NULL
.	NULL

and	NULL
Darlington	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Participation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
delta	NULL
in	NULL
the	NULL
acute-phase	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
complement	NULL
component	NULL
C3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
2584-2588	NULL
.	NULL

Kaestner	NULL
,	NULL
K.H	NULL
.	NULL

,	NULL
Christy	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Lane	NULL
,	NULL
.M.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mouse	NULL
insulin-responsive	NULL
glucose	NULL
transporter	NULL
gene	NULL
:	NULL
characterization	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
trans-activation	NULL
by	NULL
the	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
251-255	NULL
.	NULL

Katz	NULL
,	NULL
S.	NULL
,	NULL
Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
Muller	NULL
,	NULL
C.	NULL
,	NULL
Meese	NULL
,	NULL
K.	NULL
,	NULL
Ness	NULL
,	NULL
S.A	NULL
.	NULL

and	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
NF-M	NULL
transcription	NULL
factor	NULL
is	NULL
related	NULL
to	NULL
C/EBPRB	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
,	NULL
differentiation	NULL
and	NULL
leukemogenesis	NULL
of	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
1321-1332	NULL
.	NULL

Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
Twamley	NULL
,	NULL
G.	NULL
,	NULL
Ansieau	NULL
,	NULL
$	NULL
.	NULL

and	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Novel	NULL
mechanism	NULL
of	NULL
C/EBP	NULL
beta	NULL
(	NULL
NF-M	NULL
)	NULL
transcriptional	NULL
control	NULL
:	NULL
activation	NULL
through	NULL
derepression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
2781-2791	NULL
.	NULL

Kraut	NULL
,	NULL
N.	NULL
,	NULL
Frampton.J	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Rem-1	NULL
,	NULL
a	NULL
putative	NULL
direct	NULL
target	NULL
gene	NULL
of	NULL
the	NULL
Myb-Ets	NULL
fusion	NULL
oncoprotein	NULL
in	NULL
haematopoietic	NULL
progenitors	NULL
,	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
recoverin	NULL
family	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
1027-1036	NULL
Kulessa	NULL
,	NULL
H.	NULL
,	NULL
Frampton	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
GATA-1	NULL
reprograms	NULL
avian	NULL
myelomonocytic	NULL
-	NULL
cells	NULL
into	NULL
-	NULL
eosinophils	NULL
,	NULL
-	NULL
thromboblasts	NULL
-	NULL
and	NULL
erythroblasts	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
1250-1262	NULL
.	NULL

Landschulz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Johnson	NULL
,	NULL
PF	NULL
.	NULL

and	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
The	NULL
leucine	NULL
zipper	NULL
:	NULL
a	NULL
hypothetical	NULL
structure	NULL
common	NULL
to	NULL
a	NULL
new	NULL
class	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
,	NULL
240	NULL
,	NULL
1759-1764	NULL
.	NULL

Landschulz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Johnson	NULL
,	NULL
PF	NULL
.	NULL

and	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
The	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
liver	NULL
nuclear	NULL
protein	NULL
C/EBP	NULL
is	NULL
bipartite	NULL
.	NULL

Science	NULL
,	NULL
243	NULL
,	NULL
1681-1688	NULL
.	NULL

Leutz	NULL
,	NULL
A	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Molecular	NULL
cloning	NULL
of	NULL
the	NULL
chicken	NULL
myelomonocytic	NULL
growth	NULL
factor	NULL
(	NULL
cMGF	NULL
)	NULL
reveals	NULL
a	NULL
relationship	NULL
to	NULL
interleukin	NULL
6	NULL
and	NULL
granulocyte	NULL
colony	NULL
stimulating	NULL
factor	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
175-181	NULL
.	NULL

Lin	NULL
,	NULL
E.-T.	NULL
and	NULL
Lane	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Antisense	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
RNA	NULL
suppresses	NULL
coordinate	NULL
gene	NULL
expression	NULL
and	NULL
triglyceride	NULL
accumulation	NULL
during	NULL
differentiation	NULL
of	NULL
3T3-L1	NULL
preadipocytes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
533-544	NULL
.	NULL

McNagny	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Lim	NULL
,	NULL
F	NULL
,	NULL
Grieser	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
surface	NULL
proteins	NULL
of	NULL
chicken	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
thrombocytes	NULL
and	NULL
eosinophils	NULL
detected	NULL
by	NULL
novel	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Leukemia	NULL
,	NULL
6	NULL
,	NULL
975-984	NULL
.	NULL

Munn	NULL
,	NULL
D.H.	NULL
,	NULL
Beall	NULL
,	NULL
A.C.	NULL
,	NULL
Song	NULL
,	NULL
D.	NULL
,	NULL
Wrenn	NULL
,	NULL
R.W	NULL
.	NULL

and	NULL
Throckmorton	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Activation-induced	NULL
apoptosis	NULL
in	NULL
human	NULL
-	NULL
macrophages	NULL
:	NULL
developmental	NULL
regulation	NULL
of	NULL
a	NULL
novel	NULL
cell	NULL
death	NULL
pathway	NULL
by	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interferon	NULL
y.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
127-136	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
_	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
_	NULL
Sasagawa	NULL
,	NULL
T.	NULL
,	NULL
-	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
-	NULL
Naruto	NULL
,	NULL
M.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Akira	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Phosphorylation	NULL
at	NULL
threonine-235	NULL
by	NULL
ras-dependent	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
factor	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
2207-2211	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Hashimoto	NULL
,	NULL
S.	NULL
,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Isshiki	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
,	NULL
79	NULL
,	NULL
460-466	NULL
.	NULL

Ness	NULL
,	NULL
S.A.	NULL
,	NULL
Marknell	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
The	NULL
v-myb	NULL
oncogene	NULL
product	NULL
binds	NULL
to	NULL
and	NULL
activates	NULL
the	NULL
promyelocyte-specific	NULL
mim-/	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
,	NULL
1115-1125	NULL
.	NULL

Ness	NULL
,	NULL
S.A.	NULL
,	NULL
Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
Casini	NULL
,	NULL
T.	NULL
,	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Myb	NULL
and	NULL
NF-M	NULL
:	NULL
combinatorial	NULL
activators	NULL
of	NULL
myeloid	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
749-759	NULL
.	NULL

Pei	NULL
,	NULL
D.Q	NULL
.	NULL

and	NULL
Shih	NULL
,	NULL
C.H	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
An	NULL
'attenuator	NULL
domain	NULL
'	NULL
is	NULL
sandwiched	NULL
by	NULL
two	NULL
distinct	NULL
transactivation	NULL
domains	NULL
in	NULL
the	NULL
transcription	NULL
factor	NULL
C/	NULL
EBP	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1480-1487	NULL
.	NULL

Peitsch	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Polzar	NULL
,	NULL
B.	NULL
,	NULL
Stephan	NULL
,	NULL
H.	NULL
,	NULL
Crompton	NULL
,	NULL
T.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Mannherz	NULL
,	NULL
H.G	NULL
.	NULL

and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Characterization	NULL
of	NULL
the	NULL
endogenous	NULL
deoxyribonuclease	NULL
involved	NULL
in	NULL
nuclear	NULL
DNA	NULL
degradation	NULL
during	NULL
apoptosis	NULL
(	NULL
programmed	NULL
cell	NULL
death	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
371-377	NULL
.	NULL

Pham	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
Elliston	NULL
,	NULL
Nawaz	NULL
,	NULL
Z.	NULL
,	NULL
McDonnelL	NULL
,	NULL
D.P	NULL
.	NULL

,	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

and	NULL
O'Malley	NULL
,	NULL
B.W	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Antiestrogen	NULL
can	NULL
establish	NULL
nonproductive	NULL
receptor	NULL
complexes	NULL
and	NULL
alter	NULL
chromatin	NULL
structure	NULL
at	NULL
target	NULL
enhancers	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
3125-3129	NULL
.	NULL

Picard	NULL
,	NULL
D.	NULL
,	NULL
Salser	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Yamamoto	NULL
,	NULL
K.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
A	NULL
movable	NULL
and	NULL
regulable	NULL
inactivation	NULL
function	NULL
within	NULL
the	NULL
steroid	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Cell	NULL
,	NULL
54	NULL
,	NULL
1073-1080	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
Mancini	NULL
,	NULL
FP	NULL
.	NULL

and	NULL
Cortese	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
,	NULL
63	NULL
,	NULL
643-653	NULL
.	NULL

Pope	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Ness	NULL
,	NULL
S	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
C/EBP	NULL
beta	NULL
regulation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
94	NULL
,	NULL
1449-1455	NULL
.	NULL

Ramji	NULL
,	NULL
D.P	NULL
.	NULL

,	NULL
Vitelli	NULL
,	NULL
A.	NULL
,	NULL
Tronche	NULL
,	NULL
F.	NULL
,	NULL
Cortese	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Ciliberto	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
two	NULL
C/EBP	NULL
isoforms	NULL
,	NULL
IL-6DBP/NF-IL6	NULL
and	NULL
C/EBP	NULL
delta/NF-IL6	NULL
beta	NULL
,	NULL
are	NULL
induced	NULL
by	NULL
IL-6	NULL
to	NULL
promote	NULL
acute	NULL
phase	NULL
gene	NULL
transcription	NULL
via	NULL
different	NULL
mechanisms	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
21	NULL
,	NULL
289-294	NULL
.	NULL

Rebbe	NULL
,	NULL
N.F	NULL
.	NULL

,	NULL
Ware	NULL
,	NULL
J.	NULL
,	NULL
Bertina	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Modrich	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Stafford	NULL
,	NULL
(	NULL
1987	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
cDNA	NULL
for	NULL
a	NULL
member	NULL
of	NULL
the	NULL
human	NULL
90	NULL
kDa	NULL
heat	NULL
shock	NULL
protein	NULL
family	NULL
.	NULL

Gene	NULL
,	NULL
53	NULL
,	NULL
235-245	NULL
.	NULL

Scott	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
Civin	NULL
,	NULL
C.I	NULL
.	NULL

,	NULL
Rorth	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Friedman	NULL
,	NULL
A.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
80	NULL
,	NULL
1725-1735	NULL
.	NULL

Smarda	NULL
,	NULL
J	NULL
.	NULL

and	NULL
LipsickJ.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
c-Myb	NULL
prevents	NULL
TPA-induced	NULL
differentiation	NULL
and	NULL
cell	NULL
death	NULL
in	NULL
v-Myb	NULL
transformed	NULL
monoblasts	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
237-245	NULL
.	NULL

Steinlein	NULL
,	NULL
P.	NULL
,	NULL
Deiner.E	NULL
.	NULL

,	NULL
Leutz	NULL
,	NULL
A.	NULL
and	NULL
Beug	NULL
.	NULL

,	NULL
H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Recombinant	NULL
murine	NULL
erythropoietin	NULL
receptor	NULL
expressed	NULL
in	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
mediates	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

Growth	NULL
Factors	NULL
,	NULL
10	NULL
,	NULL
1-16	NULL
.	NULL

Sterneck	NULL
,	NULL
E.	NULL
,	NULL
Blattner	NULL
,	NULL
C.	NULL
,	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992a	NULL
)	NULL
Structure	NULL
of	NULL
the	NULL
chicken	NULL
myelomonocytic	NULL
growth	NULL
factor	NULL
gene	NULL
and	NULL
specific	NULL
activation	NULL
of	NULL
its	NULL
promoter	NULL
in	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
by	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
1728-1735	NULL
.	NULL

Sterneck	NULL
,	NULL
E.	NULL
,	NULL
Muller	NULL
,	NULL
C.	NULL
,	NULL
Katz	NULL
,	NULL
S	NULL
$	NULL
.	NULL

and	NULL
Leutz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992b	NULL
)	NULL
Autocrine	NULL
growth	NULL
induced	NULL
by	NULL
kinase	NULL
type	NULL
oncogenes	NULL
in	NULL
myeloid	NULL
cells	NULL
requires	NULL
AP-1	NULL
and	NULL
NF-M	NULL
,	NULL
a	NULL
myeloid-specific	NULL
,	NULL
C/EBP-like	NULL
factor	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
115-126	NULL
.	NULL

Tontonoz	NULL
,	NULL
P.	NULL
,	NULL
Hu	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Spiegelman	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Stimulation	NULL
of	NULL
adipogenesis	NULL
in	NULL
fibroblasts	NULL
by	NULL
PPAR	NULL
gamma	NULL
2	NULL
,	NULL
a	NULL
lipid-activated	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
,	NULL
79	NULL
,	NULL
1147-1156	NULL
.	NULL

Trautwein	NULL
,	NULL
C.	NULL
,	NULL
Caelles	NULL
,	NULL
C.	NULL
,	NULL
van-der-Geer	NULL
,	NULL
P	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Chojkier	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Transactivation	NULL
by	NULL
NF-IL6/LAP	NULL
is	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
activation	NULL
domain	NULL
.	NULL

Nature	NULL
,	NULL
364	NULL
,	NULL
544-547	NULL
.	NULL

Ucker	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
Obermiller	NULL
,	NULL
P.S	NULL
.	NULL

,	NULL
Eckhart	NULL
,	NULL
W.	NULL
,	NULL
Apgar	NULL
,	NULL
J.R.	NULL
,	NULL
Berger	NULL
,	NULL
N.A	NULL
.	NULL

and	NULL
Meyers	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genome	NULL
digestion	NULL
is	NULL
a	NULL
dispensable	NULL
consequence	NULL
of	NULL
physiological	NULL
cell	NULL
death	NULL
mediated	NULL
by	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
3060-3069	NULL
.	NULL

Umek	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Friedman	NULL
,	NULL
A.D	NULL
.	NULL

and	NULL
McKnight	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
CCAAT-enhancer	NULL
binding	NULL
protein	NULL
:	NULL
a	NULL
component	NULL
of	NULL
a	NULL
differentiation	NULL
switch	NULL
.	NULL

Science	NULL
,	NULL
251	NULL
,	NULL
288-292	NULL
.	NULL

Wegner	NULL
,	NULL
M.	NULL
,	NULL
Cao	NULL
,	NULL
Z	NULL
.	NULL

and	NULL
Rosenfeld.M.G	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Calcium-regulated	NULL
phosphorylation	NULL
within	NULL
the	NULL
leucine	NULL
zipper	NULL
of	NULL
C/EBP	NULL
beta	NULL
.	NULL

Science	NULL
,	NULL
256	NULL
,	NULL
370-373	NULL
.	NULL

Williams	NULL
,	NULL
G.T	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Spooncer	NULL
,	NULL
E.	NULL
,	NULL
Dexter	NULL
,	NULL
T.M	NULL
.	NULL

and	NULL
Taylor	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Haemopoietic	NULL
colony	NULL
stimulating	NULL
factors	NULL
promote	NULL
cell	NULL
survival	NULL
by	NULL
suppressing	NULL
apoptosis	NULL
.	NULL

Nature	NULL
,	NULL
343	NULL
,	NULL
76-79	NULL
.	NULL

Williams	NULL
,	NULL
$	NULL
.C	NULL
.	NULL

,	NULL
Baer	NULL
,	NULL
M.	NULL
,	NULL
Diliner	NULL
,	NULL
A.J	NULL
.	NULL

and	NULL
Johnson	NULL
,	NULL
PF	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
CRP2	NULL
(	NULL
C/EBP	NULL
B	NULL
)	NULL
contains	NULL
a	NULL
bipartite	NULL
regulatory	NULL
domain	NULL
that	NULL
controls	NULL
transcriptional	NULL
activation	NULL
,	NULL
DNA	NULL
binding	NULL
and	NULL
cell	NULL
specificity	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
3170-3183	NULL
.	NULL

Wu	NULL
,	NULL
X	NULL
.	NULL

and	NULL
Levine	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
p53	NULL
and	NULL
E2F-1	NULL
cooperate	NULL
to	NULL
mediate	NULL
apoptosis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
3602-3606	NULL
.	NULL

Received	NULL
on	NULL
July	NULL
17	NULL
,	NULL
1995	NULL
;	NULL
revised	NULL
on	NULL
September	NULL
5	NULL
,	NULL
1995	NULL
Differentiation	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
C/EBPB	NULL
6135	NULL

